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Abstract
Sudden infant death syndrome is the largest single cause of death of infants between
1 week and 12 months of age in this country, and although public awareness of the
risk factors involved has increased over the last few years, the incidence of SIDS still
stands at approximately 0.7 per 1000 live births in Scotland. The aim of this study
was to examine how infection might play a role in SIDS in relation to developmental
and environmental risk factors identified in epidemiological studies by examining
the binding of bacterial toxins to human cells and their effects, singly and in
combination on induction of inflammatory mediators.
There is a correlation between the incidence of SIDS, isolation of Staphylococcus
aureus and expression of the Lewisa blood group antigen in the 2 to 4 month age
range. Lewis3 has previously been shown to act as a surface receptor for certain
bacteria on human epithelial cells, the first stage of this study was to develop a
screening method to detect adhesins that bind Lewis3 on toxigenic strains of S.
aureus and other bacteria isolated from SIDS infants. Additional experiments
indicated that some of the superantigenic toxins of S. aureus utilise this antigen as a
receptor on monocytes and are capable of stimulating the production of
inflammatory mediators from these cells.
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The pertussis toxin of B. pertussis is capable of binding to Lewis3 and Lewisx and it
has been suggested that asymptomatic whooping cough is one cause of S1DS.
Changes in the age range of SIDS infants were observed between 1988 and 1994,
after the DPT immunisation schedule was changed from 3 months to 2 months of age
in October 1990. The protective effect of DPT immunisation suggested in several
large epidemiological studies was examined with reference to antigenic cross
reactivity between the DPT vaccine and the staphylococcal toxins. Results obtained
in enzyme linked immunosorbent assays (ELISA) indicated that antibodies cross-
reactive with the staphylococcal toxins were produced by rabbits in response to DPT
immunisation. Assays for nitric oxide production by human monocytes in response to
the toxins indicated that the antibodies were able to neutralise partially some of the
inflammatory activities of the toxins.
In animal models the combined effects of nicotine, endotoxin and virus infection
enhanced the lethal effects of the staphylococcal toxins. These agents, separately and
in combination, were examined for their ability to induce TNF-a and nitric oxide
from human monocytes. Synergy between toxins in induction of these mediators was
shown to occur with several toxin combinations, particularly SEB plus TSST-1 or
endotoxin.
Incubation of human monocytes infected with respiratory syncytial virus (RSV) or
with a water soluble cigarette smoke extract (CSE) was found to alter the
2
inflammatory responses of these cells to TSST-1, generally by induction of increased
TNF-a levels and decrease of the nitric oxide response.
These studies help to explain the effects of some of the developmental and
environmental risk factors associated with SIDS which could contribute to the series





The sudden and unexpected death of an infant is not a new phenomenon, though
from the earliest available reference in the Bible, dating to approximately 500 BC
until the 19th century such deaths appear to have been attributed solely to overlaying.
Asphyxiation resulting from the obstruction of breathing by bed clothes or the
infants' carer was a feasible hypothesis given that the incidence of bed sharing was
then far higher than that which occurs in present day western society. In the early
1830s this view was superseded by another single cause hypothesis, that of status
thymo-lymphaticus [reviewed by Valdes-Dapena, 1995] or airway obstruction caused
by a pathologically enlarged thymus causing compression of the trachea. This
hypothesis was also widely accepted and not disputed until the mid 1940s when the
first steps to examine the problem of cot death systematically were made.
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Given the scarcity of evidence available, the hypotheses put forward to explain cot
deaths have been remarkably varied and many have been found to be inaccurate.
Theories as diverse as allergic reaction to aspirated cow's milk [Parish et al., 1960]
and failures of the immune system (hypogammaglobulinaemia) [Spain et al., 1954]
have been put forward and have generally been disproved. Several of the current
hypotheses are discussed below (1.5). During the 1960s and 1970s public awareness
of the problem of cot death increased and there was a corresponding increase in cot
death research, both of its pathology and its epidemiology. The epidemiological data
gained from studies carried out in several different countries identified many of the
predisposing factors, such as socio-economic class, birth weight and race which
guide current research on the problem of sudden infant death syndrome (SIDS).
1.2 Diagnosis and definition.
SIDS is the largest cause of death in infants in industrialised countries between the
ages of 1 week and 12 months, accounting for approximately 50% of the total
number of deaths in this age range and having an incidence of approximately 0.7 per
1000 live births in Scotland during 1995 [Brooke et al., 1997], The current working
definition of SIDS as proposed by Beckwith in 1970 is:
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"The sudden death of an infant or young child which is unexpected by
history, and in a thorough post-mortem examination fails to demonstrate an
adequate cause ofdeath.''''
This definition, although there are currently calls to modify it, demonstrates our lack
of understanding of why certain infants die within the first months of life. Entering a
verdict of SIDS in a post-mortem report is not a diagnosis but rather the only
conclusion left after all other possible explanations for the infants' death have been
found inadequate. This does not, however mean that all SIDS infants appear totally
normal at autopsy. Several pathological findings are commonly associated with the
syndrome.
1.3 Pathological findings in SIDS victims at autopsy.
Petechial haemorrhages, small areas of blood in the mucous membranes, are
commonly present throughout the lungs, along the coronary arteries and the thoracic
lobe of the thymus. Occasionally they are present beneath the epicardium (Table
1.1).
Diffuse interstitial oedema in the lungs is one of the most common findings in SIDS
victims at autopsy. Pathological changes in the upper respiratory tract are also
frequently observed, including inflammatory cell infiltration in the nasopharynx,
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larynx and trachea and thickening of the basement membrane of the epithelium in
the larynx and trachea [Keeling, 19??].
Pathological changes in the brain are also noted at autopsy, including brain stem
astrocytic gliosis involving the nucleus ambiguus and the dorsal motor nucleus of the
vagus [Takashima et al., 1978] which may be the result of infection or a hypoxic
episode but could also have produced hypoxia by affecting the normal regulation of
breathing. Detachment of ependymal cells from the ventricular lining of the brain is
occasionally observed. This too can be indicative of hypoxia/ischaemia or a minor
infection [Keeling, 19??].
7
Table 1.1 Typical postmortem findings in SIDS [Berry and Keeling, 1989],
External:
Well nourished, normally developed baby
Frothy blood-tinged fluid around the nose (50%)
Hypostatic staining often anterior indicating
face-down position
Cyanosis of the lips and nailbeds
Internal:
"Large" thymus with petechiae (80%)
Petechiae beneath visceral pleura
Epicardial petechiae
Full expansion of the lungs
Liquid heart blood (80%)
Prominent lymph nodes and Peyer's patches
Empty bladder (50%)
Microscopic:
Pulmonary congestion and oedema
Mild inflammation of the upper respiratory tract
Focal fibrinoid necrosis of the vocal cords
Persistent haemopoiesis in the liver
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1.4 Risk factors associated with SIDS.
Risk factors associated with SIDS are summarised in table 1.2.
1.4.1 Smoking.
Maternal smoking during pregnancy has long been accepted as a modifiable risk
factor in SIDS with several studies showing a dose-dependent relationship between
smoking and increased risk of SIDS. An approximate sevenfold increase in risk was
noted in one study when the mother smoked more than twenty cigarettes per day
[Murphy et al., 1982], Other studies have found similarly high increases in risk
which remain significant after controlling for potentially confounding factors such as
maternal age and socio-economic class [Poets et al., 1995], It has, however, only
been recently that postnatal exposure to cigarette smoke from either the mother or
other family members has been addressed as a risk factor in its own right [Mitchell et
al., 1993; Schoendorf and Kiely, 1992; Blair et al., 1996; Brooke et al., 1997],
1.4.2 Young maternal age.
SIDS deaths are more common in infants ofmothers under the age of 25 and the risk
increases with increasing birth order. The combination of these two factors increases
the risk of a SIDS death by a far higher factor than would be expected if this were
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merely an additive effect, such that a second born child of a mother aged under 20
would be seven times more likely to die of S1DS than that born to a mother aged 25
or over [Gibson, 1992],
1.4.3 Gender.
The male/female ratio of SIDS deaths is approximately 1.6:1. This disparity is not
seen in non-SIDS infant deaths and may be due to later development of physiological
control mechanisms in males [Gibson, 1992] or an increased susceptibility of male
infants to respiratory tract infections [Ruuskanen and Ogra, 1993],
1.4.4 Prone sleeping position.
The prone sleeping position is acknowledged as a strong risk factor for SIDS which
has resulted in educational campaigns to discourage the placing of infants in this
position in many countries worldwide with a corresponding decrease in SIDS
incidence [Willinger et al., 1996; Bacon et al., 1996; 0yen et al., 1996], It is,
however, still common in SIDS deaths [Bacon et al., 1996; Brooke et al., 1997],
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1.4.5 Socio-economic background.
The confidential enquiry into stillbirths and deaths in infancy (CESDI) (England)
case-control study (SIDS n=T95, controls n=780) found the risk of SIDS to be greater
in families of a lower socio-economic background. Factors studied included
unemployment, housing conditions and parental education [Bensley et al., 1996],
These findings are consistent with those of Brooke et al. [1997] (Scotland), Taylor
and Sanderson, [1995] (U.S.A) and Daltveit et al. [1996] (Scandinavia), however, it
is difficult to isolate any one of the socio-economic markers as a risk factor for SIDS
as the relationship between them is so complex.
1.4.6 Low birth weight.
Analysis of suspected risk factors in several long-term epidemiological studies has
provided conflicting results which appear to depend to a large extent on country,
ethnic group and the method of statistical analysis used in the study. By univariate
analysis, low birth weight (<2,500 g) was identified as a significant risk factor in the
Scottish study of Brooke et al., [1997] (SIDS n=147, controls n=276) and in an
American study by Li and Daling, [1991] (SIDS n=916, controls n=3,704).
Subsequent multivariate analysis of the Scottish study, correcting for gestational age,
showed this risk factor to be non-significant. Although multivariate analysis of the
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American data was not performed, comparison of the various ethnic groups
represented in the study showed that low birth weight was only a significant risk
factor among whites, American Indians and blacks, not among Asians or Hispanics.
Gestational age was not controlled for in this study, however, as a number of ethnic
groups were studied, low birth weight was defined as being below the population
mean minus 1.96 standard deviations.
1.4.7 Excess heating.
The studies ofFleming et al., [1990] and Brooke et al., [1997] found that a combined
thermal rating (tog value) of bedding and clothing greater than 10 was a significant
risk factor by univariate analysis. Over-heating is thought to play a role in enhancing
the effect of infection to precipitate a SIDS death in certain infants [Gilbert et al.,
1992],
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Table 1.2 Developmental and environmental risk factors for SIDS.
Risk factor Reference
Peak incidence in 2-4 month age range Gibson, 1992
Brooke et al1997
Mild respiratory tract infection Williams et al., 1984
Gilbert et al., 1992
Exposure to cigarette smoke Mitchell, 1996
Blair et al., 1996
Brooke et al., 1997
Prone sleeping position Fleming et al., 1990
Beal, 1995
Blair et al., 1996
Brooke et al., 1997
Bottle rather than breast fed Ford et al., 1993
No immunisation or late immunisation Hofman et al., 1987
Walker et al., 1987
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1.5 Hypotheses to explain SIDS.
1.5.1 Prenatal/developmental.
1.5.1.1 Metabolic deficiencies.
It is estimated that approximately 10% of SIDS cases result from a metabolic
deficiency [Bonham and Downing, 1992], but this figure is uncertain as such
deficiencies are not commonly tested for on post-mortem derived material. Studies
into the role of metabolic deficiencies in SIDS have concentrated on two main areas:
defects in glucose homeostasis and defects in fatty acid metabolism.
Abnormal development of the enzymes involved in gluconeogenesis or glycogen
metabolism will result in functional immaturity of the mechanisms which control
glucose homeostasis thus rendering the infant susceptible to potentially fatal
episodes of hypoglycaemia. The likelihood of such episodes occurring can be greatly
exacerbated by environmental factors such as low calorie intake and minor clinical
or sub-clinical infections [Burchell et al., 1992], Failure of mitochondrial fatty acid
oxidation limits the amount of ketone bodies available to the brain and muscles as an
alternative source of energy in the event of depletion of glycogen stores, again
resulting in potentially fatal hypoglycaemic episodes.
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1.5.1.2 Developmental anomalies of the lungs.
It has been hypothesised that a percentage of SIDS deaths may be caused by failure
of lung development in utero, thus reducing the surface area available for gaseous
exchange and increasing the risk of hypoxic episodes. A recent study [Beech et al.,
1996] found that the total number of terminal ducts was significantly reduced in low
birth weight infants (both controls and SIDS cases) and in normal birth weight SIDS
cases. The gas exchange surface density was also found to be significantly reduced in
normal and low birth weight SIDS cases compared to normal birth weight controls.
1.5.2 Perinatal.
1.5.2.1 Temperature regulation and heat stress.
An increase in body heat and metabolic rate in response to bacterial or viral infection
might lead to a fatal event if heat loss is prevented by excessive amount of clothing.
As the brain accounts for 40% of the total oxygen usage in young infants [Gilbert et
al., 1992], the head is a major site of heat production. It is also the most effective
area of heat loss [Nelson et al., 1989; Wailoo et al., 1989], Any interference with
heat loss from the head, e.g. bed covers or a hat, could lead to heat stress in the brain
even without a concomitant increase in core temperature [Gilbert et al., 1992];
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however, the combination of infection and overwrapping is only associated with risk
of death in infants over 10 weeks old, possibly due to these infants being less
vulnerable, and therefore, requiring more risk factors to cause a fatality.
Alternatively, the higher levels of body fat and increased metabolic rate to surface
area ratio render these infants more susceptible to thermal stress than younger infants
in whom other temperature regulation mechanisms may be important [Gilbert et al.,
1992], Such failures of temperature regulation have been associated with an increase
in apnoeic episodes [Ford et al., 1996] as well as enhancement of the inflammatory
response to infection.
1.5.2.2 Delayed development of the "adult-like" temperature pattern.
Infants' night time temperature patterns switch to an "adult-like" pattern at about 11
weeks of age (range=7 to 22 weeks), and elevation of night-time temperature can
occur in response to immunisation and minor infection [Peterson et al., 1996], Other
physiological changes are associated with the change in night-time temperature
pattern, the decrease in weight of the adrenal glands in the first 2 months of life is
associated with decreased plasma levels of Cortisol [Wittekind et al., 1993],
Circadian variations in Cortisol secretion have been observed in adults with the
lowest secretion rates occurring in the early hours of the morning when the majority
of SIDS deaths are thought to occur. This drop in night-time Cortisol secretion occurs
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in the week following the switch to the adult-like body temperature rhythm [Peterson
and Wailoo, 1994], As Cortisol and the other glucocorticoids play a major role in the
control of inflammatory responses [Reichlin, 1993], reduced levels of these
hormones during a period when both maternal and infant antibody levels are
insufficient to neutralise infectious agents and toxins could result in a period of
susceptibility to the detrimental effects of inflammatory mediators. If the switch in
temperature pattern occurs after the infant's antibody response has developed, the
likelihood of sudden death due to an uncontrolled inflammatory response will be
reduced. This view is supported by evidence that Asian infants, in whom the switch
in temperature pattern occurs significantly later than in white infants have a lower
incidence of SIDS [Peterson and Wailoo, 1992],
1.6 Similarities between SIDS and bacterial infections of the
respiratory tract.
Research into the cause of sudden infant death syndrome over the last thirty years
has frequently examined the involvement of infectious agents. The literature contains
many reports of the isolation of various toxigenic bacteria and viruses from SIDS
victims at autopsy, and several hypotheses have been put forward as to how these
infectious agents could have caused death. As the only sources of this data are post
mortem reports and epidemiological studies, there is no direct evidence that these
17
microorganisms actually caused the death of the infant. The diagnosis of SIDS
precludes any findings of fatal septicaemia or viraemia, and it is the lack of a set of
recognisable signs at autopsy attributable to a specific pathology which presents one
of the major problems in SIDS research, "where to start"? This question is best
addressed by comparison of SIDS autopsy findings and epidemiological data with
those ofmore easily recognisable pathologies.
1.6.1 Evidence from pathological observations.
The role of micro-organisms in SIDS deaths is unclear, pathological changes
attributed to bacteria and viruses observed at autopsy cannot, under the current
definition, appear to be sufficient to cause the death of a previously healthy infant.
There is, however, indirect evidence that micro-organisms may be involved as minor
inflammation of the respiratory tract is observed in about 60% of SIDS cases [Berry,
1992]. These pathological findings are consistent and indicate activation of the
infant's inflammatory or immune responses (Table 1.3).
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1.6.2 Epidemiological evidence for infection in SIDS.
The factors associated with susceptibility to infection, particularly respiratory tract
infection, are similar to those associated with SIDS [Gibson, 1992], During the 2 to 4
month age range in which the majority of SIDS cases occur there is a window of
susceptibility to infection caused by the decrease in levels of maternal
transplacental^ acquired immunoglobulins occurring prior to the infants'
development of active immunity to a variety of infectious agents.
The seasonality of SIDS, though questioned recently for certain geographical
locations [Fleming et al., 1996; Kiberd, 1996], still appears to hold in most countries
with the majority of SIDS cases occurring during the winter months when there is a
higher incidence of respiratory tract infections [Williams et al., 1984],
The incidences of both SIDS [Scragg et al. 1993] and respiratory tract infections
[Bonham et al., 1981; Pershagen, 1986] is higher in the infants of smokers compared
with non-smokers. Other recognised risk factors for SIDS are also associated with
susceptibility to infection including bottle feeding [Arnon, 1984, Ford et al., 1993];
the risk of SIDS is reduced in breast fed infants which are protected to a certain
extent from respiratory and gastrointestinal pathogens by components of colostrum
and breast milk including serum, leucocytes and antibodies. Infants born to families
from the lower socioeconomic groups have been identified as being at risk from
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SIDS by several studies though this could reflect the influence of several other risk
factors such as maternal smoking, bottle feeding, poorer housing and lower levels of
health care also linked with lower socioeconomic class.
Susceptibility to infection and possibly to SIDS can be affected by genetic and
developmental factors as well as environmental ones. Epidemiological studies have
found associations between blood group and susceptibility to several diseases of both
infectious and non-infectious aetiology. Epidemiological evidence of the association
between the ABO blood group antigens and secretor status and infectious diseases
was reviewed by Blackwell [1989a]. Individuals who are unable to secrete the
glycoprotein forms of the ABO blood group antigens in body fluids (non-secretors)
have been found to be more susceptible than secretors to a wide range of bacterial
and fungal diseases. This increased susceptibility has been demonstrated in
infectious diseases including bacterial meningitis [Blackwell et al., 1986] and also
auto-immune conditions such as rheumatic fever [Haverkorn and Goslings, 1969],
thyrotoxicosis [Collier et al., 1988] and insulin dependent diabetes mellitus
[Blackwell et al., 1989; Aly etal., 1991; 1992a,b].
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1.7 Secretor status and the Lewis blood group antigens.
1.7.1 Genetic control of secretor status.
Secretion of the ABO blood group antigens is controlled by allelic genes, Se and se,
on chromosome 19 [Watkins, 1980] and is inherited as a Mendelian dominant
character. An individual homozygous (SeSe) or heterozygous (Sese) for the secretor
gene is termed a "secretor" whereas those homozygous for the silent allele (sese) are
termed "non-secretors". Among the European population approximately 75 to 80%
are secretors and 20 to 25% are non secretors, the ratio of secretors to non-secretors
varies between different ethnic groups [Race and Sanger, 1975],
Secretor status can be determined by detection of the ABO blood group antigens in
the saliva using a haemagglutination inhibition test or by determination of the Lewis
blood group antigens as the secretor gene regulates expression of the Lewis
phenotype [Race and Sanger, 1975],
1.7.2 Biochemistry of the Lewis system.
The product of the Lewis gene (Le) is an a-4/3-L-fucosyltransferase that adds an a-
L-fucosyl residue to the subterminal N-acetylglucosamine of the H or Type 1
22
precursor chains. The Lewis3 (Lea) determinant contains L-fucose joined at the C-4
position of the subterminal N-acetylglucosamine of a Type 1 precursor chain. The
b bLewis (Le ) determinant has two fucosyl residues attached to adjacent sugars, one
linked to the N-acetylglucosamine as in the Lewis3 determinant and the other linked
to the terminal p-galactosyl residue by the fucosyl transferase coded for by the
secretorgene [Watkins, 1980] (Figure 1.1).
Unlike the ABO antigens which are synthesised endogenously by erythrocytes, the
Lewis blood group antigens are produced at a distant and as yet unknown site and
released into the plasma as glycosphingolipids carried by high- and low-density
lipoproteins [Hammar et al., 1981; reviewed in Henry el al., 1995] from where they
are adsorbed into the cells membrane. The Lewis3 antigen (Le3) is found
predominantly on the cells of non-secretors whereas secretors primarily express the
Lewisb antigen (Leb), although they are capable of expressing varying quantities of
Lewis3 [Issit, 1985], During early neonatal development, however, the fucosyl
transferase coded for by the Lewis gene reaches functional maturity faster than that
of the secretor gene. This allows the enzyme coded for by the Lewis gene to add
fucose to the subterminal sugar of the Type 1 precursor chain first thus rendering the
substrate unavailable to the enzyme coded for by the secretor gene. This results in
the majority of infants in the 2 to 4 month age range expressing large quantities of
the Lewis3 antigen which will drop to adult levels by two years of age (Figure 1.2).
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Figure 1.1 Biosynthesis of the Lewis antigens.
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Age in months
Figure 1.2 Expression of the Lewis® antigen in the first 18 months of life.
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1.8 Micro-organisms associated with SIDS.
1.8.1 Viruses.
The epidemiological evidence for involvement of respiratory viruses in SIDS cases is
inconsistent [Carpenter and Gardner, 1990; Uren et al., 1980], No studies have
shown a systemic viraemia or elevated levels of interferon-y, nor has a single
predominant virus or family of viruses been identified in studies of SIDS victims
[Ford et al., 1990; Nelson et al., 1975; Fleming, 1992], Those isolated from SIDS
cases include influenza [Zink et al., 1987], respiratory syncytial virus (RSV)
[Williams et al., 1984], rhinovirus [Las Heras and Swanson, 1983], rotavirus [Yolken
and Murphy, 1982], and adenoviruses [An et al., 1993], Given the technical
difficulties of isolating viruses from post-mortem samples the extent of viral
involvement in SIDS may have been underestimated in the past [Flemming, 1992];
however, a more recent survey found no differences in isolation of viruses from
SIDS cases and controls matched for age, time of year and geographic area [Gilbert
et al., 1992],
One study has provided a possible link between the mild respiratory tract infection
commonly noted in SIDS victims the week prior to death [Stanton et al., 1978] and
the actual fatal event. Bruhn et al. [1977] reported an association between RSV
infection and prolonged sleep apnoea.
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1.8.2 Bacteria.
There are two main ways in which bacteria can cause acute disease:
(1) Invasion of areas of the body which are normally sterile e.g. meningitis;
(2) Production of toxins by bacteria on mucosal surfaces e.g. diphtheria and
pertussis.
Of these, the invasive bacteria can be immediately ruled out as a cause of SIDS as
they leave clear indications of their presence. Given that the pathological effects of
endotoxin are usually associated with invasive bacterial diseases many of the studies
on bacterial involvement in SIDS have concentrated on species which colonise
mucosal surfaces and produce diffusible toxins which enter the bloodstream. Both
enteric and respiratory bacteria have been isolated from SIDS cases (Table 1.4), but
the pathology and epidemiology of SIDS has more in common with that of the
respiratory bacteria than those found in the gastrointestinal tract.
Two of the toxigenic bacteria which colonise the respiratory tract have been
implicated in SIDS: Bordetella pertussis, the causative organism of whooping cough
[Nicoll and Gardner, 1988; Lindgren el a/., 1997], and Staphylococcus aureus
[Morris et al., 1987; Newbould et a/., 1989; Telford et al., 1989; Malam et al.,
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1992], B. pertussis has not been isolated from a SIDS case though its potential
involvement has not been ruled out given the difficulty of isolating this organism,
even from infants with symptomatic whooping cough [Davis et al., 1990],
Epidemiological studies on SIDS during periods of unusually high whooping cough
prevalence have indicated a correlation between infection with B. pertussis and SIDS
[Nicoll and Gardner, 1988; Lindgren et al., 1997], Toxigenic strains of S. aureus
have been isolated from SIDS victims in several studies [Telford et al., 1989;
Murrell et al., 1993].
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Table 1.4 Toxigenic bacteria isolated from SIDS victims.
Species Toxin Superantigen Reference
S. aureus enterotoxins, TSST-1 yes Newbould etal., 1989
Malam et. al., 1992
Murrell et al., 1993








endotoxin yes Telford etal., 1989
Oppenheim et al., 1994
Clostridium
perfringens
enterotoxin A yes Murrell et al., 1987
Lindsay et al., 1993
Streptococcus
pyogenes





Bettleheim et al., 1989; 1990
Oppenheim et al., 1994
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1.8.2.1 Factors enhancing frequency or density of colonisation of
infants by pathogenic bacteria.
1. Frequency of colonisation:
The frequency of isolation of potentially pathogenic bacteria is higher in people who
smoke compared with non-smokers [Blackwell et al., 1990; 1992], An increased
frequency of isolation is also observed during the winter months which parallels
SIDS, this may be due to the higher incidence of respiratory viral infections during
this season.
2. Density of colonisation:
The density of bacterial colonisation of mucosal surfaces is an important factor in
the initiation of both invasive and toxigenic bacterial diseases [Beachey, 1981],
Several risk factors enhance the ability of bacteria implicated in SIDS to bind to
epithelial cells:
The Lewis3 antigen acts as an epithelial cell surface receptor for certain bacterial
adhesin molecules, including those expressed by S. aureus [Saadi et al., 1993] and B.
pertussis [Saadi et al., 1996], The Lewis3 antigen is expressed by 80 to 90% of
infants in the 2 to 4 month age range and as can be seen in figure 1.3 this peak in
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expression correlates with the highest rate of isolation of S. aureus and incidence of
SIDS. Infection of the human epithelial cell line Hep-2 with respiratory syncytial
virus results in a significant increase in the binding of pertussis, staphylococci and
haemophilus over uninfected Hep-2 cells [Saadi et al., 1993; Saadi et al., 1996; Raza
et al., 1993], Epithelial cells sampled from smokers bind greater numbers of
staphylococci, pertussis and H. influenzae than those taken from non-smokers [Saadi
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Figure 1.3 Comparison ofLewis3 expression, SIDS incidence and isolation of
S. aureus in Scotland by age.
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1.9 The possible role of bacterial toxins in sudden infant death
syndrome.
The hypothesis examined in this work is that the toxins produced by certain common
bacteria can, under some conditions, cause the death of a previously healthy infant
via uncontrolled production of inflammatory mediators.
The role of S. aureus in relation to SIDS was examined in this study as it is a
toxigenic bacterium which fits closely the mathematical model of bacterial infection
in SIDS proposed by Morris et al. [1987] which predicts that the infant population
will encounter the bacteria involved in precipitating the series of events culminating
in SIDS within the first 50 days of life. There is a correlation between the incidence
of isolation of S. aureus and that of SIDS (Figure 1.3) and studies by Newbould et al.
[1989] and Malam et al. [1992] have demonstrated the presence of staphylococcal
enterotoxin C (SEC) and toxic shock syndrome toxin (TSST-1) in tissue samples of
SIDS victims. Factors associated with SIDS such as concomitant viral infection and
exposure to tobacco smoke have been shown to enhance the binding of S. aureus to
human cells. While certain of these factors have also been shown to enhance binding
of B. pertussis, the role of this organism in SIDS is more speculative as it has not
been isolated from SIDS cases [Saadi et al., 1993; Saadi et al., 1996a],
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Although S. aureus is isolated from over 50% of healthy infants in the 2 to 4 month
age range, not all of them become SIDS victims. Certain factors must be present to
produce a fatal outcome from a minor infection. In this age range the susceptibility
of an infant to colonisation by potentially pathogenic bacteria will be influenced by
the factors mentioned above: Lewisa antigen expression; exposure to tobacco smoke;
underlying viral infection; and low maternal and infant antibody levels. Once
colonisation of the upper respiratory tract has occurred whether the bacteria will
grow and produce toxins will be determined by whether or not the colonising strain
possesses the genes for toxin production and if the permissive temperature range in
which the toxins are induced is reached. The pyrogenic toxins of S. aureus are only
produced between 37 and 40°C. This is higher than the usual temperature of the
upper respiratory mucosal surfaces which are cooled by the passage of air as the
infant breathes. The temperature of this area could however, be increased, for
example by:
1. overwrapping - excessive amounts of clothing or blankets may raise body
temperature and reduce exposed surface area for heat loss;
2. the prone sleeping position - heat loss from the face is reduced, the cooling effect
of the passage of air over the mucosal surfaces is reduced, and rebreathing of
warm, recently exhaled air will occur;
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3. mild viral infection - blocking one or both nostrils with catarrh reducing air flow
and induction of pyrexia.
These factors could elevate the temperature of the mucosal surfaces thus creating a
suitable micro-enviromnent for the production of toxins (see Figure 1.4). The
pyrogenic effect of the toxins themselves would also act to maintain the elevated
temperature, prolonging their production. Recent evidence indicates that in older
children (3-8 years) the prone position significantly increases the temperature of the
nasal passages [Moloney et al., submitted for publication].
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Figure 1.4 Factors leading to colonisation of infants by potentially pathogenic
bacteria and induction of pyrogenic toxins.
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1.9.1 Synergy between infectious agents.
1.9.1.1 Synergy between bacterial toxins and viruses.
Several groups have examined interactions between bacterial toxins and viruses.
Animal studies using neonatal ferrets have shown that infection with the influenza
virus can enhance the animals response to staphylococcal a and y toxins, as well as
to endotoxin and diphtheria toxin by factors ranging from 3 to 84 [Jakeman et al.,
1991], Similar results were observed by Lundemose et al. [1993] in a study of
cytokine production by human leucocytes in response to influenza virus and
endotoxin from E coli. In vivo studies using mice showed that sub-clinical infection
with lymphocytic choriomeningitis virus had a similar effect on enhancing the
lethality of staphylococcal enterotoxin B (SEB) at normally tolerable levels. Partial
protection was afforded by neutralisation of TNF-a by soluble receptor proteins and
blockade of nitric oxide production by aminoguanidine. Neutralisation of interferon-
y by monoclonal antibodies had no effect on survival rates [Sarawar et al., 1994],
This enhanced effect may result from an auto-amplification of the cytokine
responses to the different infectious agents. Production of tumour necrosis factor-a
by monocytes/macrophages in response to extracellular bacteria can be enhanced by
the action of interferon-y which is produced in response to viral infection [Matic and
Simon, 1992], while the lymphocyte stimulating activity of TNF-a can enhance IFN-
y production [Stevens et al., 1993], The very high levels of cytokines which could
37
result from such a positive feedback loop could result in the death of an infant by
multiple organ failure [Stevens et al., 1993] (Figure 1.5)
1.9.1.2 Synergy between pyrogenic toxins and endotoxin.
The endotoxins (lipopolysaccharide, LPS) of Gram negative bacteria are potent
stimulators of B cells and mononuclear phagocytes on their own, capable of causing
fatal septic shock mediated by TNF-a at high concentrations. When present in low
concentrations, LPS causes stimulation of mononuclear phagocytes, thus augmenting
their cytokine response to other toxins. This lethal synergistic effect between
bacterial exotoxins and LPS from different species has been demonstrated in the
chick embryo model [Drucker et al., 1992; Sayers et al., 1995a]. Further evidence of
a role for LPS in SIDS includes the recent observations that some SIDS infants had
significantly lower IgG antibodies and elevated IgM antibodies to endotoxin core
[Oppenheim et al., 1994], and the fact that staphylococci are often isolated along
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Figure 1.5 Synergy between viral infections, endotoxins and pyrogenic toxins in
induction of inflammatory mediators (Mq> = macrophage).
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1.9.1.3 Synergy between pyrogenic toxins.
Many of the toxigenic strains of S1. aureus produce more than one type of toxin. Of
those which colonise humans, it is common to find isolates producing TSST-1 and
SECi. Previous studies have shown that the toxicity of this combination is greater
than that of TSST-1 alone or in combination with any of the other staphylococcal
enterotoxins [Crass and Bergdoll, 1986], S. aureus isolates producing TSST-1 and
SEC have been implicated in SIDS [Newbould et al., 1989; Malam et al., 1992],
1.9.1.4 Synergy between products of cigarette smoke and bacterial
toxins.
The work of Sayers et al. [1995b], using the chick embryo model, demonstrated that
the lethality of small amounts of toxins produced by bacteria isolated from SIDS
cases could be greatly enhanced by the addition of a concentration of nicotine equal
to that produced in man by 0.05 cigarettes. This enhancement of lethality by nicotine
was further increased when toxins were present in combination.
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1.9.2 The staphylococcal toxins as superantigens.
1.9.2.1 Mode of action of superantigens.
The staphylococcal enterotoxins and TSST-1 are termed superantigens because of
their ability to stimulate a large percentage of T cells resulting in high levels of
cytokines which can cause shock. Superantigens cause non-antigen-specific
proliferation of T cells by binding outwith the antigen binding groove of MHC class
II molecules on antigen presenting cells and cross-linking with the p chain variable
(VP) region of the T cell antigen receptor (TcR). For example, Vp2 is associated
with TSST-1 and Vp8 with SEB [Kappler et al., 1989], In this way all T cells
bearing a specific VP sequence in their TcR are stimulated (Figure 1.6).
1.9.2.2 Structure of the staphylococcal superantigens.
The toxins produced by S. aureus are a group of structurally related single chain
proteins of relatively low molecular mass. They are serologically classified into five
groups, SEA, B, C, D and E, though SEC contains three subtypes. A further
staphylococcal toxin, originally named SEF was later renamed toxic shock syndrome
toxin (TSST-1). The toxins share the physical characteristics of being charged and
heat and protease stable. There are also structural and sequence similarities, a
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centrally located disulphide loop is present in all of the toxins except TSST-1 and all
are rich in serine, threonine, and aspartic acid residues. Similarities in primary
sequence are most clearly seen between SEA and SEE which exhibit approximately
90% sequence homology [Callahan et al., 1990] though SEB and the SEC subtypes
also appear to be related, showing approximately 65% homology at the amino acid
level [Singh et al., 1988], These similarities continue at the secondary structure
level, circular dichroism (CD) analysis has shown that the staphylococcal
enterotoxins have a low a helix and high p pleated sheet content (Table 1.5).
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Figure 1.6 Comparison of conventional and superantigen binding: (a) Conventional
antigen recognition, (b) Superantigen recognition outwith the antigen
binding groove of the MHCII molecule, (c) Binding and stimulation of
large numbers of non-antigen specific T cells.
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Table 1.5 Characteristics of the staphylococcal enterotoxins.
Molecular Isoelectric CD Structure (%)
Toxin Mass (kDa) Point (pi) g helix (3 sheet
SEA 27.8 7.3 11 36
SEB 28.3 8.6 10 55
SEQ 26.0 8.6 15 38
TSST-1 24.0 7.2 6 51
(Adapted from Johnson et al., 1991).
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1.9.2.3 Pathological response to staphylococcal superantigens.
The staphylococcal toxins were recognised in the early 1960s as a cause of food
poisoning, inducing weakness, pyrexia and vomiting, not as a result of damage to the
intestinal tissues but by the excessive production of interleukin-2 (IL-2) from
proliferating T cells. Superantigen binding can induce autoimmunity, in which T
cells recognising self-antigens proliferate. This can also depress immunity, directly
by non-specific suppression of immunoglobulin synthesis [Poindexter and Schlievert,
1986], and indirectly when the T cells die off following superantigen stimulation and
are therefore unavailable to respond to any subsequent infection. Staphylococcal
toxins are known to cause toxic shock syndrome and have been implicated in
Kawasaki disease by enhancement of clones bearing the V|32 sequence on their TcR
[Leung etal., 1995],
Possibly the most pertinent effect of the staphylococcal enterotoxin superantigens in
relation to sudden infant death syndrome is their ability to enhance lethal endotoxin
shock. In a rabbit model the pyrogenic toxins were shown to enhance the lethality of
endotoxin by up to 100,000 fold [Sugiyama et al., 1964; Schlievert, 1982], This is
thought to be due to alteration of liver clearance function by blockade of the
reticuloendothelial system [Fujikawa et al., 1986], Similar enhancement of
endotoxin effect is seen with TSST-1 in the renal tubular cells of rat kidneys [Keane
etal., 1986],
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Although the majority of research into superantigen function has concentrated on
TcR binding and T cell stimulation, studies on the effect of MHC class II
engagement by these antigens on a variety of human cells, particularly macrophages,
has shown similarly high levels of stimulation and production of cytokines including
interleukin-1 (IL-1) [Ikejima et al., 1984] and tumour necrosis factor a (TNF-a)
[Fast et al., 1988; Parsonnet and Gillis, 1988],
1.9.3 How could common bacterial toxins cause a SIDS death?
In the first few months of life when maternal antibody levels have waned initial
protection from infectious agents is provided by the acute inflammatory response. It
is possible that a certain percentage of SIDS deaths result from pathophysiological
inflammatory responses to microbial products, both bacterial and viral, possibly
augmented by environmental factors such as exposure to cigarette smoke, occurring
during a time when cytokine controls are not sufficiently developed to damp down
the production and effects of inflammatory mediators and endocrine responses
cannot cope with the effects of these mediators on glucose homeostasis.
The cytokine response which results in inflammation is also involved in the process
of septic shock in which the cytokines rather than the bacterial products cause most
of the clinical signs [Parrillo, 1993],
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The early stages of septic shock in adults may be asymptomatic. In some infants
SIDS could be the result of septic shock which has been fatal before the
histopathological signs of an inflammatory response have had time to develop. This
outcome has been termed "pre-morbid shock" [Stevens et al., 1993],
Production of TNF-a from mononuclear phagocytes can be elicited by both
endotoxin and the pyrogenic exotoxins and initiates a cytokine cascade including IL-
1, IL-6, TNF-a itself, and low molecular weight inflammatory cytokines of the IL-8
family, which play important roles in mediating septic shock [Newbould et al., 1989;
Parrillo 1993], It is the co-stimulatory and synergistic effects of these and other
inflammatory mediators that lead to shock and death. IFN-y produced in response to
viral infection augments production and many of the potentially lethal actions of
TNF-a, as well as enhancing nitric oxide synthase activity [Stevens et al., 1993],
1.9.3.1 A possible role for inflammatory mediators in SIDS deaths.
Work on the induction of septic shock in a rabbit model by TSST-1 has shown that
many of the clinical observations associated with a shock state are due to the
production of TNF-a and IL-1 [Ikejima el al., 1988]. The researchers noted that the
major organ affected by TSST-1 was the lungs which showed diffuse petechial
haemorrhages similar to those of SIDS victims. On administration of a combination
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of TNF-a and IL-1 haemorrhage was again noted, and in addition, proteinaceous
fluid and immune cells were found in the alveolar spaces [Okusawa et al., 1988],
There are several possible means by which an excessive cytokine response to a
minor toxic stimulus could trigger a fatal event in a susceptible infant:
1. Reduction of blood pressure and tissue perfusion: TNF-a and nitric oxide are both
capable of causing a significant reduction in blood pressure. TNF-a reduces
myocardial contractility and causes relaxation of vascular smooth muscle tone both
directly and indirectly by stimulating the production of vasodilators such as NO and
prostacyclin from the vascular endothelium. Nitric oxide is thought to further lower
blood pressure by altering endothelial integrity thus causing vascular leakage [Ochoa
et al., 1992], Tissue perfusion can be decreased by high levels of TNF-a causing the
formation of intravascular thromboses via endothelial alterations promoting
coagulation and vascular plugging by activated neutrophils [Stevens et al., 1993],
2. Hyperthermia: TNF-a and IL-1 induce fever via the production of prostaglandins
from cytokine-stimulated hypothalamic cells which would account for the very high
temperatures recorded for some SIDS infants [Sunderland and Emery, 1981],
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3. Disturbance of glucose homeostasis: Systemic TNF-a causes severe metabolic
disturbances including a potentially fatal drop in blood glucose levels [Stevens et al.,
1993],
4. Sleep apnoea: The increased frequency of sleep apnoeas during respiratory
infections [Steinschneider, 1972] are thought to be due to IL-1 and muramyl peptide
from bacterial cell walls inducing periods of deep sleep [Guntheroth, 1989], Nitric
oxide is also capable of producing hypoxic events when produced in high local
concentrations by cytokine stimulated airway epithelial cells, probably by increasing
bronchial blood flow and plasma exudation into the airways thus obstructing
breathing [Kuo et al., 1992; Alving et al., 1993],
5. Uncontrolled stimulation of inflammatory cells: IL-1 has a stimulatory activity on
effector cells of the immune and inflammatory responses. Along with TNF-a it acts
on macrophages to produce further IL-1 and induce synthesis of IL-6, termed the
acute phase response, which results in rapid and drastic changes in plasma protein
composition thought to enhance the efficacy of the inflammatory response. Control
of IL-1 is by a naturally occurring inhibitor, a biologically inactive structural
homologue, produced by macrophages stimulated by antibody/antigen complexes
[diGiovine and Duff, 1990], Given that the infants antibody levels at this stage of
development will be minimal or absent, inhibition of IL-1 by this method will not be
efficient.
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6. Synergistic effect of cytokines: Interferon-y (IFN-y) produced by T cells and
natural killer (NK) cells in response to viruses and TSST-l[Jupin et al., 1988] is a
potent activator of macrophages which not only enhances TNF-a synthesis at the
transcriptional level but also augments many of the effects of TNF-a on endothelial
cells. Both TNF-a and IL-1 cause an up-regulation of IFN-y receptors on monocytes,
presumably to increase the capacity of IFN-y to activate the cell [Krakauer and
Oppenheim, 1993], IL-1, though incapable of causing tissue damage itself,
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Figure 1.7 Synergistic effects between cytokines.
1.10 Aims of this study.
The aim of this study was to examine the role of developmental and environmental
risk factors associated with SIDS in relation to the hypothesis that common bacterial
toxins are involved in precipitating some of these infant deaths.
The principal objectives were:
1. to assess the ability of various bacterial strains to bind to the Lewis3 antigen
which is known to act as a cell surface receptor for some bacterial species and
bacterial toxins and is expressed by the majority of infants in the 0 to 3 month
age range;
2. to determine if, as is the case for the pertussis toxin, the enterotoxins of
Staphylococcus aureus can bind to the Lewis3 antigen on human peripheral blood
mononuclear cells;
3. to assess the level of antigenic cross-reactivity between the staphylococcal
enterotoxins and other common bacterial toxins to examine the possible
protective effect reported for diphtheria-pertussis-tetanus vaccination;
52
4. to examine additive or synergistic effects between the staphylococcal
enterotoxins and lipopolysaccharide from E. coli in induction of the
inflammatory mediators nitric oxide and tumour necrosis factor-a from human
peripheral blood mononuclear cells;
5. to examine the role of cigarette smoke components and virus infection on




General materials and methods
All chemicals were reagent grade and obtained from BDH unless otherwise
specified.
2.1 Toxins and anti-toxins.
The toxins and anti-toxins used in these studies are listed in Tables 2.1 and 2.2.
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Table 2.1 Toxins and suppliers.
Toxin Source
Staphylococcal enterotoxin A S. aureus
Staphylococcal enterotoxin B S. aureus
Staphylococcal enterotoxin Q S. aureus
Toxic shock syndrome toxin-1 S. aureus








Table 2.2 Antibodies and suppliers.
Antibody Source Supplier
Anti-SEA Rabbit Toxin Technology Inc.
Anti-SEB Rabbit Toxin Technology Inc.
Sigma
Anti-SEC i Rabbit Toxin Technology Inc.
Anti-TSST-1 Rabbit Toxin Technology Inc.
HRP anti-SEA Rabbit Toxin Technology Inc.
HRP anti-SEB Rabbit Toxin Technology Inc.
HRP anti-SEC! Rabbit Toxin Technology Inc.
HRP anti-TSST-1 Rabbit Toxin Technology Inc.




2.2 Enzyme linked immunosorbent assays (ELISA).
2.2.1 ELISA reagents.
2.2.1.1 Coating buffer.
The coating buffer contained NaHC03 1.59 g, NaH2C03 2.93 g and NaN3 (Sigma)
0.2 g in 1 litre of distilled water, pH 9.6.
2.2.1.2 Phosphate buffered saline (PBS).
Phosphate buffered saline contained Na2HP04 (Fisons) 4.08 g, NaH2P04 2.0 g and
NaCl (Sigma) 3.04 g in 1 litre of distilled water, pH 7.2.
2.2.1.3 Washing buffer.
The washing buffer contained PBS with 0.1% bovine serum albumin (BSA) (w/v)
(Sigma) and 0.02% Tween 20 (v/v).
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2.2.1.4 Blocking buffer.
Phosphate buffered saline plus 1% BSA (w/v).
2.2.1.5 Phosphate citrate buffer.
Phosphate citrate buffer contained of 21 g of citric acid and 14.2 g of Na2HP04 in 1
litre of distilled water, pH 5
2.2.1.6 Substrate.
Ortho-phenylenediamine dihydrochloride (OPD) (Sigma) (0.04 g) added to 100 ml of
phosphate citrate buffer and activated with 40 pi H202 (Sigma) (30%, v/v)
immediately prior to use.
2.2.1.7 Stopping solution.
The enzymatic reaction was stopped with 12.5% (v/v) H2S04 in distilled water.
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2.3 Tissue culture: culture media, supplements and cells.
2.3.1 Dulbecco's modified Eagle's medium.
Dulbecco's modified Eagle medium (DMEM) (Sigma) was used as the basis of the
culture media for both human peripheral blood monocytes and L-929 cells and is
referred to throughout as DMEM with no additives. Culture media consisted of
DMEM with L-glutamine (Gibco) (2 mM), penicillin (Gibco) (100 IU mf!) and
streptomycin (Gibco) (100 pg mf1), referred to throughout as DMEM with additives.
2.3.2 Human peripheral blood monocytes.
Monocytes were collected from buffy coats supplied by the Scottish National Blood
Transfusion Service (SNBTS) using a Ficoll-hypaque gradient (Sigma tissue culture
grade Histopaque-1077 Hybri-Max) by the following method. The buffy coats were
diluted 1/2 in sterile PBS to a volume of 40 ml and layered onto 8 ml of Ehstopaque
in a 50 ml conical centrifuge tube (Greiner). The tubes were centrifuged at 400 x g
for 30 min at room temperature and the interface layer containing the monocytes
removed. The monocytes were washed twice in sterile PBS at 150 x g for 10 min and
the supernatant discarded. The cells were resuspended in 20 ml of DMEM with
additives plus 15% (v/v) fetal calf serum (FCS) (Sigma), transferred to a 75 cm2
58
tissue culture flask (Greiner) and incubated at 37 °C for 30 min to separate
monocytes from non-adherent blood cells. The medium containing non-adherent
cells was poured off and the monocytes harvested by gentle scraping with a cell
scraper in 20 ml of fresh DMEM with additives plus 15% FCS. A viable count was
performed using the Trypan blue dye exclusion method and the concentration of
monocytes adjusted to 2 x 106 cells ml"1 in DMEM with additives plus 15% FCS.
2.3.3 L929 cells.
The tumourigenic murine fibroblast cell line L-929 was obtained from the European
Collection of Animal Cell Cultures (ECACC) (Porton Down, Salisbury, England).
Cells were cultured in DMEM with additives plus 10% (v/v) FCS at 37°C in a 5%
C02 atmosphere until they had reached a semi-confluent state.
2.4 Monocyte challenge assay.
2.4.1 Toxin challenge.
The monocyte suspensions were placed in the wells of a sterile 24 well tissue culture
plate (Greiner) in 0.5 ml volumes (1 x 106 cells/well) and the toxins added as 0.5 ml
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volumes of twice the desired final concentration for single toxin assays or 0.25 ml
volumes of four times final concentration for synergy or blocking studies involving
either 2 toxins or toxin and antibody respectively. The plate was incubated for 3 days
at 37°C in a 5% C02 atmosphere. The supernatants were extracted from the wells
and centrifuged at 1,250 x g to remove cellular debris and stored at -20°C prior to
assaying for nitric oxide and tumour necrosis factor-a content.
2.5 Nitrite assay.
2.5.1 Nitrite detection method.
Nitric oxide production was assayed by measurement of the stable breakdown
product nitrite in the culture supernatant which reacts with the Greiss reagent to form
a purple azo dye, the method was adapted from Zhang et al., [1994], The
supernatants (400 pi) were placed in 4 ml test tubes (Greiner) and mixed with an
equal volume of Greiss reagent. The tubes were incubated for 10 min at room
temperature and read at 570 nm on a Jenway 6100 spectrophotometer.
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2.5.2 Greiss reagent.
Naphthylethylenediamine dihydrocloride (Sigma) 0.3% w/v in distilled water mixed
1:1, immediately prior to use with sulfanilamide (Sigma) 1% w/v in 5% cone. H2P04.
The components of the Greiss reagent were prepared fresh for each experiment.
2.5.3 Nitrite standard.
Dilutions of NaN02 (Sigma) in distilled water were used as the nitrite standard and
included in each experiment.
2.6 Bioassay for detection of TNF-a.
L929 mouse fibroblast cells were grown to confluence in 75 cm tissue culture flasks
(Greiner), one day old monolayers were trypsinised, washed and adjusted to 3 x 105
viable cells mf1 in Dulbecco's modified Eagle's medium (DMEM) plus 10% FCS
before being distributed in 100 pi volumes into sterile 96 well flat bottom tissue
culture plates. The plates were incubated overnight at 37°C in a 5% C02 atmosphere.
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The medium was replaced with 50 pi volumes of the cell supernatant or TNF-a
standards. The wells were made up to 100 pi with fresh DMEM plus 10% FCS
containing 2 pg mf1 actinomycin D (Sigma) and the plates incubated overnight as
above.
The supernatants were removed from the wells, the plates blotted dry and 50 pi
volumes of 0.5% crystal violet (w/v) in 20% methanol (v/v) in distilled water were
added and incubated at room temperature for 2 minutes. The excess stain was
washed offwith tap water and the plates dried using a hair dryer. Acetic acid (20%,
v/v in distilled water) was added to the wells and the optical density at 570 nm
determined with a Dynatech MR 700 plate reader.
2.6.1 TNF-a standard.
Natural human tumour necrosis factor-a (88/786) was obtained from the National
Institute for Biological Standards and Control (NIBSC) and a range of dilutions from
0 to 100 IU mf1 included in each experiment.
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2.7 Sodium dodecyl sulphate (SDS) polyacrylamide gel
electrophoresis (PAGE).
2.7.1 SDS PAGE buffers and solutions.
All solutions were made up in distilled water. Gloves were worn during the
preparation and subsequent handling of acrylamide solutions.
2.7.1.1 Electrode buffer.
The electrode buffer contained 0.025 M Tris, 0.192 M glycine and 0.1% (w/v) SDS,
pH 8.3.
2.7.1.2 Separating gel buffer.
The separating gel buffer contained 0.75 M Tris-HCl at pH 8.8 plus SDS (0.2% w/v).
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2.7.1.3 Stacking gel buffer.
The stacking gel buffer contained 0.25 M Tris-HCl at pH 6.8 plus 0.2% w/v SDS.
2.7.1.4 Acrylamide stock solution.
Acrylamide stock solution (40% w/v) contained 100 g acrylamide (BDH
Electrophoresis Grade) and 2.7 g methylene bis acrylamide (BDH Electrophoresis
Grade) in 250 ml of distilled water.
2.7.1.5 Separating and stacking gels.
The separating and stacking gels were prepared as described in Table 2.3. The gel
solutions were prepared in thoroughly cleaned filtration flasks and de-gased by
applying a controlled negative pressure to the flask using a vacuum pump prior to
addition of TEMED (NNN'N'-tetramethyl-l,2-diaminoethane) and ammonium
persulphate.
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2.7.2 SDS PAGE method.
An electrophoresis cassette was made, consisting of 2 glass plates (160 mm x 125
mm x 2mm) thoroughly cleaned with methanol separated by 1.5 mm plastic spacers
and clamped together using 2 bulldog clips per spacer. The sides and bottom of the
cassette were sealed with molten Vaseline.
A 12% separating gel (Table 2.3) was poured into the cassette using a 20 ml syringe
and 19g needle to within 4 cm of the top of the cassette and allowed to set. A 4%
stacking gel (Table 2.3) was poured onto the separating gel and a comb to form the
sample wells inserted. After the stacking gel had set, the comb was removed, the
cassette placed in an electrophoresis tank (Jencons Scientific Ltd.) and electrode
buffer (2.7.1.1) added.
Heat denatured samples (2.7.3) were added to the wells in 20 pi volumes and
electrophoresed through the stacking gel at 60 V constant voltage and through the
separating gel at 150 V constant voltage until the dye front was within 30 mm of the
bottom of the cassette. The cassette was then removed from the electrophoresis tank
and the glass plates separated to allow removal of the gel for staining.
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Table 2.3 Preparation of polyacrylamide gels.
12% separating gel 4% stacking gel
Distilled water 5.2 ml 3.5 ml
Separating buffer 17.5 ml -
Stacking buffer - 5.0 ml
Acrylamide solution 10.5 ml 1.0 ml
TEMED 0.05 ml 0.02 ml
Ammonium persulphate 1.75 ml 0.5 ml
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2.7.3 Preparation of samples for polyacrylamide gel electrophoresis.
Protein samples for PAGE were adjusted to 100 pg ml"1 in distilled water and mixed
1:1 with sample buffer. The samples were then heated at 100 °C in a water bath to
denature the protein.
2.7.3.1 Sample buffer.
Sample buffer contained Tris (4% w/v), SDS (20% v/v), glycerol (2% v/v), 2-
mercaptoethanol (1% v/v) and bromophenol blue (0.002% v/v), pH 6.8.
2.7.4 Coomassie blue staining of polyacrylamide gels for protein.
The polyacrylamide gels were stained for protein using the method of Hancock and
Poxton (1988). The gels are incubated in a series of 3 staining and 2 decolourising
solutions. The gels are incubated overnight in solution 1 and then sequentially in
solutions 2 to 5, each for 1 h at room temperature with gentle shaking in an orbital
incubator (Gallenkamp) at 30 rpm.
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2.7.4.1 Staining solution 1.
Staining solution 1 contained propan-2-ol (25% v/v), acetic acid (10% v/v) and
Coomassie brilliant blue R-250 (0.05% w/v).
2.7.4.2 Staining solution 2.
Staining solution 2 contained propan-2-ol (10% v/v), acetic acid (10% v/v) and
Coomassie blue (0.005%).
2.7.4.3 Staining solution 3.
Staining solution 3 contained acetic acid (10% v/v) and Coomassie blue (0.0025%).
2.7.4.4 Decolourising solution 1.
Decolourising solution 1 contained methanol (40% v/v) and acetic acid (10% v/v).
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2.7.4.5 Decolourising solution 2.
Decolourising solution 2 contained acetic acid (10 % v/v).
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CHAPTER 3
Detection of microbial surface antigens that
bind Lewis3
3.1 Introduction
Individuals who are non-secretors of their ABO blood group antigens are over
represented among patients with certain infectious diseases or carriers of potentially
pathogenic micro-organisms: rheumatic fever and carriers of group A Streptococcus
pyogenes [Glynn et al., 1956, Haverkorn and Goslings, 1969]; meningococcal
disease [Blackwell et al., 1986a]; invasive disease due to type b Haemophilus
influenzae [Blackwell et al., 1986b]; oral and vaginal yeast infections [Thorn et al.,
1989, Aly et al., 1991] and oral carriers of yeasts [Burford-Mason et al., 1988,
Blackwell et al., 1989b, Aly et al., 1992]; patients with peptic ulcers resulting from
infection with Helicobacterpylori [Mourant et al., 1978], One hypothesis put
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forward to explain these epidemiological findings is that some strains of micro¬
organisms have adhesins that bind to the Lewis3 antigen which is usually expressed
in greater quantities on epithelial cells of non-secretors compared with secretors
[Blackwell, 1989a; Blackwell, 1989b; Blackwell et al., 1992].
Among older children and adults, the proportion of individuals whose erythrocytes
are agglutinated by anti-Lewis3 is generally 20 to 25%. Between the ages of 2 to 4
months, approximately 80 to 90% of infants express the antigen on their erythrocytes
[Issit, 1985], but this declines to the levels expected in adults by 18 to 24 months.
Lewis3 antigen on epithelial cells is adsorbed from secretions and Lewis3 is readily
detectable in the body fluids of infants [Blackwell et al., 1992; Raza et al., 1991],
Among infants who had died of SIDS the Lewis3 antigen was identified in the
respiratory secretions of 71% [Blackwell et al., 1992; Saadi et al., 1993],
It has been observed that binding of Staphylococcus aureus to epithelial cells was
positively correlated with the amount of Lewis3 detected on the epithelial cells of
individual donors by flow cytometry. Binding of the strains could be significantly
reduced by pre-treating the epithelial cells with the monoclonal anti-Lewis3 used to
detect the antigen in flow cytometric assays [Saadi et al., 1993], A protein from outer
membrane preparations of a toxigenic staphylococcal strain has been isolated by
affinity purification methods using synthetic Lewis3 [Saadi et al. 1994a], Lewis3,
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Lewisb and H type 2 antigen have also been identified as receptors for adhesins on
Candida albicans [Cameron and Douglas, 1996] and H. pylori [Alkout etal., 1997],
Studies in which antibodies to host cell epitopes were used to inhibit bacterial
binding have been criticised on the grounds that the antibody is binding not to the
receptor for the bacteria but to an antigen in close proximity to the proposed
receptor. The inhibition observed is due to stearic hindrance. One approach to
dealing with these criticisms is production of anti-idiotypic antibodies to the
antibodies used in the binding inhibition assays. Anti-idiotypic antibodies are raised
to the antigen binding portion of a primary antibody, the Fab portion. The Fab of the
anti-idiotypic antibody has a conformation which is a mirror image of that of the Fab
portion of the primary antibody therefore the Fab portion of the anti-idiotypic
antibody will resemble the structure of the antigen to which the monoclonal antibody
binds [Koprowski etal., 1984],
The objectives of this part of the project were:
1. To produce an anti-idiotypic antibody to monoclonal anti-Lewisa.
2. To determine if the anti-idiotypic antibodies could bind to strains of
micro-organisms that express surface components which bind Lewis3.
72
3. To develop a reagent to determine if the anti-idiotypic antibodies could
be used in a rapid screening method to detect surface components on
pathogenic micro-organisms that bind to Lewis3.
3.2 Materials and methods.
3.2.1 Monoclonal antibodies.
Monoclonal anti-Lewis3 antibodies LM 112/161.8, LM 112/159.1, LM 112/160.4 and
anti-Lewisb antibodies LM 137/264.2 and LM 137/268 were kindly provided by Dr.
Robin Frazer of SAPU, Carluke, Lanarkshire. The monoclonal and polyclonal anti-
Lewis antibodies used for cell typing and antibodies to the blood group antigens were
obtained from SNBTS (Table 3.1).
LM 112/161.8 was purified by affinity chromatography with synthetic Lewis3
conjugated to Synsorb beads (Chembiomed). The bound antibody was eluted by 2%
(w/v) ammonia in 0.9% (w/v) saline (pH 11) at room temperature. After dialysis to
remove the ammonia, the final protein concentration was estimated
spectrophotometrically and adjusted to 40 pg ml"1.
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3.2.2 Determination of protein concentration.
The method of Bradford (1976) was used to determine the concentration of the
eluted antibody. The antibody solution (100 pi) was made up to 5 ml in protein
reagent (Coomassie Brilliant Blue G-250 (0.01%, w/v), ethanol (4.7%, v/v) and
phosphoric acid (8.5%, w/v) in 1 L distilled H20). The two solutions were mixed by
repeated inversion for 2 min. and left to stand for 30 min. to allow the dye to bind to
the protein. The sample was then read at 595 nm on a Jenway 6100
spectrophotometer, the protein weight read against a standard curve of known
weights of bovine serum albumin and the concentration adjusted to 40 pg ml"1.
3.2.3 Preparation of immunogen.
Purified anti-Lewisa (LM 112/161.8) (2 ml of a solution containing 40 pg ml"1) was
conjugated with keyhole limpet haemocyanin (KLH) by adding 0.1 ml of a 1 in 5
dilution of a stock solution of glutaraldehyde (6.5%, v/v) and 0.1 ml of KLH (10 mg
ml"1). After incubation for 1 hr at room temperature, 0.1 ml of 1M lysine was added
and the solution dialysed overnight against phosphate buffered saline (PBS) (2.2.1.2).
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Table 3.1 Monoclonal antibodies to blood group antigens.
Antibody Source Ig class Supplier
Anti-Lea 112/159.1 Mouse IgM SAPU
Anti-Lea 112/160.4 Mouse IgM SAPU
Anti-Lea 112/161.8 Mouse IgM SAPU
Anti-Leb 137/264.2 Mouse IgM SAPU
Anti-Leb 137/268 Mouse IgM SAPU
HRP anti-mouse IgG Rabbit IgG SAPU
Anti-Lea Mouse IgM SNBTS
Anti-Leb Mouse IgM SNBTS
Anti-A Mouse IgG SNBTS
Anti-B Mouse IgG SNBTS
Anti-M Mouse IgG SNBTS
Anti-N Mouse IgG SNBTS
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3.2.4 Immunisation procedure.
Female BALB/c mice (n=3) were injected subcutaneously with the KLH-antibody
conjugate (5 pg anti-Lewisa) emulsified in Freund's complete adjuvant (0.5 ml)
followed 1 week later by 5 pg of anti-Lewis3 conjugated to KLH in incomplete
adjuvant (0.5 ml). After 6 weeks the mice were immunised with a further 5 pg of the
antibody conjugate in PBS (0.5 ml). The mice were bled 7 days later and the serum
separated by centrifugation at 100 x g for 15 min.
3.2.5 Detection of anti-idiotypic antibodies.
An ELISA to detect the anti-idiotypic IgG against anti-Lewis3 was adapted from that
used in previous studies [Zorgani et al. 1992], Two-fold dilutions of the affinity
purified anti-Lewis3 used to immunise the mice were prepared (1/10 to 1/80) in
coating buffer (2.2.1.1). The dilutions (100 pi) were used to coat 96 well flat bottom
microtitre plates (Immulon II, Dynatech) and the plates incubated overnight at 4°C.
The antibody was removed from the plates and they were washed three times with
washing buffer (2.2.1.3) with a microtitre plate washer (Dynatech). Blocking buffer
(2.2.1.4) (100 pi), was added to all wells for 30 min at room temperature then
removed. Similar plates were prepared using monoclonal anti-Lewisb (1/10 to 1/80)
to coat the plates.
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Normal mouse serum and the immune sera were diluted 1/50, 1/250 and 1/500 in
blocking buffer and 100 )ll1 added to the plates. After 45 min at 37°C in an orbital
shaking incubator, the plates were washed three times and horseradish peroxidase
(HRP) conjugated anti-mouse IgG (SAPU) (100 pi) diluted 1/500 in blocking buffer
was added to the plates. The plates were incubated at 4°C overnight then washed as
before. The substrate (2.2.1.6) (100 pi) was added to each well. The plates were
incubated at room temperature in the dark for 15 min to allow the colour to develop
and the reaction stopped with 12.5% (v/v) H2S04 (50 pi). The colour change was
measured at 492 nm on a Dynatech MR700 plate reader. Negative controls included
wells to which only coating buffer or blocking buffer but no test or control serum
was added.
3.2.6 Purification of the anti-idiotypic antibody against anti-Lewisa.
Sepharose 4B beads (Pharmacia) were reconstituted and washed twice in 10~3 M
HC1. The supernatant was discarded, coupling buffer (NaHC03 8.7 g and NaCl 29.2
g in 1 L distilled H20) was added to the Sepharose and mixed on a rotary mixer for
10 min before centrifugation at 40 x g. This process was then repeated and the
supernatant discarded after each wash. Affinity purified monoclonal anti-Lewisa was
diluted 1/2 to a volume of 4 ml in coupling buffer and added to the Sepharose beads.
The Sepharose was incubated on a rotary mixer at room temperature for 2 h then
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centrifuged at 40 x g for 10 min to remove unbound antibody. The Sepharose was
washed in coupling buffer by rotary mixing for 10 min and centrifuged at 40 x g for
10 min. Ethanolamine (1 M) (5 ml) was added to the Sepharose to block any
remaining active groups and incubated on a rotary mixer at room temperature for 2 h
before centrifugation at 40 x g for 10 min. The supernatant was discarded and the
Sepharose washed 3 times by centrifugation at 40 x g for 10 min with alternate
buffers, acetate (10 ml 1M acetic acid plus 2.92 g NaCl in 1 L distilled H20, pH 4)
and bicarbonate (NaHC03 8.4 g plus NaCl 58.4 g in 1 L distilled H20, pH 8). The
Sepharose 4B coupled to anti-Lewis3 was stored at 4°C in NET buffer (NaCl 8.7 g,
EDTA 14.88 g and Tris 4.8 g in 1 L distilled H20).
The immune mouse serum was diluted 1/100 and 2 ml added to the Sepharose beads
in a plastic universal container and incubated overnight at 4°C on a rotary mixer.
Unbound serum components were removed by centrifugation at 40 x g for 10 min.
The Sepharose was washed twice in NET buffer for 10 min on a rotary mixer and
centrifuged at 40 x g for 10 min. The supernatant was retained for further cycles of
purification. The anti-idiotypic antibodies were eluted from the Sepharose by mixing
with 1 ml of 1 M acetic acid (pH 4) for 10 min and centrifugation at 40 x g. The
supernatant was removed and neutralised with an equal volume of 1 M Tris (pH 10).
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3.2.7 Separation of the anti-idiotypic antibody from non-
immunoglobulin material on protein A conjugated Sepharose 4B.
Protein A conjugated Sepharose beads (Pharmacia) were reconstituted as described
above and stored in NET buffer. The supernatant obtained by affinity purification
with the anti-Lewis3 conjugated to Sepharose 4B was added to the protein A
conjugated Sepharose and incubated for 2 days at 4°C on a rotary mixer. The non-
immunoglobulin material was removed from the protein A Sepharose by washing
five times in NET buffer by centrifugation as above (3.2.5). The protein A Sepharose
linked to the anti-idiotypic antibody was stored in 2 ml ofNET buffer at 4°C.
3.2.8 Agglutination assay to detect the anti-idiotypic antibody on the
protein A Sepharose beads.
The specificity of the anti-idiotypic antibody bound to the protein A Sepharose beads
was assessed by an agglutination assay against anti-mouse IgG, anti-Lewis3, anti-
Lewis'3 (SAPU) and monoclonal typing antibodies against the blood group antigens
A, B, M and N (SNBTS). The Sepharose beads were placed on slides (30 pi) and
mixed with antibody (10 pi) diluted 1/4 in PBS. The slides were incubated at room
temperature for 10 min and any agglutination of the Sepharose beads noted. The test
slides were compared with negative controls containing the anti-idiotypic reagent
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plus PBS and unconjugated Sepharose 4B with anti-Lewis3, anti-Lewisb and the
typing antibodies.
3.2.9 Co-agglutination assay.
The co-agglutination assay was developed using the anti-idiotypic antibodies
conjugated to the protein A Sepharose beads to screen bacteria and yeast isolates for
surface antigens that bind Lewis3. A heavy suspension of bacteria or yeasts (10 pi)
was mixed with the protein A Sepharose bound to the anti-idiotypic antibody (30 pi)
on slides and incubated at room temperature for 10 min. Agglutination of test
samples was assessed by eye and compared with the control slides (3.2.7) with the
inclusion of an unconjugated protein A Sepharose control. Bacteria and yeasts that
agglutinated were tested for auto-agglutination by incubation with PBS.
3.2.10 Micro-organisms.
S. aureus strains NCTC 8531, NCTC 10652, NCTC 10654, NCTC 10655, NCTC
11965 were purchased from the National Collection of Type Cultures; 41206 was
kindly provided by Dr. J. Medcroft, Public Health Laboratory Service, Reading,
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Berkshire; and the Oxford strain was obtained from the departmental teaching
collection (Table 3.2) all were grown on nutrient agar.
Neisseria meningitidis (18 strains) were from the laboratory culture collection. Those
with prefixes "AK" or "I" were obtained from patients and carriers in Greece; the
remainder were isolated from patients and carriers in Scotland. The antigenic
phenotypes were confirmed by Dr. R. J. Fallon, Meningococcal Reference
Laboratory (Scotland), Ruchill Hospital, Glasgow (Table 3.4). For Neisseria
gonorrhoeae 2 strains were tested, a serum sensitive strain (8865) with "complex"
lipo-oligosaccharide (LOS) type and serum resistant strain (757) with "simple" LOS
[Winstanley et a/., 1983] (Table 3.3). All neisseriae isolates were grown on modified
New York City medium [Young, 1978],
There were 13 isolates of Haemophilus influenzae (Table 3.5) those with the "H"
prefix were patient strains obtained from Dr. Kristin Jonsdottir, Department of
Microbiology, University of Iceland. The remainder were carrier isolates kindly
supplied by Dr. Marina Barbour, Oxfordshire Department of Public Health. These
were cultured on boiled blood agar. They were serotyped by agglutination with type
specific serum (Wellcome Diagnostics).
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Three isolates of Helicobacter pylori (table 3.6) obtained from patients with peptic
ulcers were supplied by Dr. A. F. Mentis, Department of Microbiology, Hellenic
Institute Pasteur, Athens, Greece. The strains were maintained on Skirrow medium in
a microaerophillic environment.
Two isolates of Candida albicans (Table 3.7) one with an adhesin inhibitable by
fucose (GDH 2346) and one with an adhesin inhibitable by N-acetyl galactosamine
(GDH 2023) [Critchley and Douglas, 1987] were kindly provided by Dr. Julia
Douglas, Department ofMicrobiology, University of Glasgow. These were grown on
malt agar.
3.3 Results.
3.3.1 Detection of the anti-idiotypic antibody in immune mouse sera.
The ELISA results showed a pattern of decreasing optical density relative to
increasing dilution in 2 of the immune sera (L1R0 and L0R1) tested against
monoclonal anti-Lewis3 and also to a small extent in the normal mouse serum
(NMS), subsequent haemagglutination assays using monoclonal antibodies to the
Lewis antigens indicated the presence of an antigen cross-reactive with the anti-
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Lewis antibodies on lysed mouse erythrocytes present in normal mouse serum
(Figure 3.1). A similar pattern was observed with plates coated with anti-Lewisb
antibody but at lower levels in both the immune and normal mouse sera (Figure 3.2).
Serum L0R1 gave the highest O.D. readings with anti-Lewis3 but values similar to
that of the non-immunised mouse serum with anti-Lewisb. Serum L1R0 gave the
highest O.D. readings with anti-Lewisb but values slightly higher than the non¬
immune mouse serum with anti-Lewis3. The L0R1 serum was used in the preparation
of the Sepharose beads for agglutination studies.
3.3.2 Specificity of the protein A Sepharose reagent.
The anti-idiotypic antibody bound to the protein A Sepharose beads was strongly
agglutinated by anti-mouse IgG antibodies, the monoclonal anti-Lewis3 which was
used for the immunisation and 2 additional monoclonal anti-Lewis3 antibodies tested.
Weak agglutination indicated that there was cross-reactivity with anti-Lewisb but no
agglutination was observed with the antibodies to other blood groups (Table 3.2).
The results indicate that the component bound to the protein A Sepharose beads was
an IgG which is specific for anti-Lewis3 and the shared structure in anti-Lewisb; the
paratope of the Fab portion of the anti-idiotypic antibody appeared to have a





Figure 3.1 Detection by ELISA ofbinding of immune and normal mouse sera




Figure 3.2 Detection by ELISA ofbinding of immune and normal mouse sera
(NMS) to monoclonal anti-Lewisb.
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Table 3.2 Agglutination of the anti-idiotypic antibody on Sepharose beads by blood
grouping antibodies and anti-mouse IgG.
Antibody Agglutination
Anti-mouse IgG + + +
Anti-Lewis3 159.1 + + +
Anti-Lewis3 160.4 + + +







3.3.3 Co-agglutination assay using the anti-idiotypic reagent.
3.3.3.1 S. aureus.
The strongest agglutination observed was for strains of S. aureus. All strains,
including 4 toxigenic isolates were agglutinated (Table 3.3). None of the bacteria
tested caused agglutination of the unconjugated protein A Sepharose control. A
protein A negative strain was not available for testing; therefore the possibility that
the agglutination was non-specific cannot be eliminated.
3.3.3.2 N. gonorrhoeae.
For gonococci, the serum sensitive strain 8865 was agglutinated but the serum
resistant strain 757 was not (Table 3.4).
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Table 3.3 Agglutination of S. aureus isolates by the anti-idiotypic reagent.
Strain Toxin Agglutination
NCTC 8532 - + +
NCTC 10652 SEA +
NCTC 10654 SEB + +
NCTC 10655 SEC + + +
NCTC 11956 SEA, TSST-1 + +
41206 SEB +
Oxford - ++
Table 3.4 Agglutination ofN. gonorrhoeae isolates by the anti-idiotypic reagent.
Strain LOS type Agglutination
757 simple -
8865 complex + +
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3.3.3.3 N. meningitidis.
Of the 18 strains of meningococci examined, 10 (56%) were agglutinable (Table
3.5). Agglutination by the anti-idiotypic reagent was not associated with serogroup,
serotype or subtype of the bacteria; 3 carrier strains were autoagglutinable (4691, I
156 and I 642).
3.3.3.4 H. influenzae.
Of the 9 serotype b isolates ofH. influenzae examined, 6 (67%) were agglutinable, as
were 1 of the 2 type e and 1 of the 2 type f isolates tested (Table 3.6).
3.3.3.5 H. pylori.
Of the 3 isolates ofH. pylori only 1 was agglutinated by the reagent (Table 3.7).
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Table 3.5 Agglutination ofN. meningitidis isolates by the anti-idiotypic reagent
(* indicates autoagglutinable strain).
Source Strain Phenotvoe Agglutination
Greece AK 2 B:2b:P1.10 +
AK 8 B:2b:Pl. 10 +
AK 11 B:NT:P1.9 + +
AK 15 P:2b:P1.10 + +
AK 22 B:2b:P1.10 +





1156 Yx- + + *
1545 B:2b:P1.2 -
1642 B:4:P1.15 + + *
Scotland A 14 C:2b:P1.2 -
A 43 B:4:P1.15 -
4315 B:-> -
4691 NG» -f *
4813 Bx- + +
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Table 3.6 Agglutination ofH. influenzae isolates by the anti-idiotypic reagent.
Source Strain Type Agglutination
Iceland H 14 b +
H 25 b +












Table 3.7 Agglutination ofH. pylori isolates by the anti-idiotypic reagent.
Source Strain Agglutination
Greece H 203a -
H 205a +
H 206a -






The strain of C. albicans with the fucose inhibitable adhesin was agglutinated but the
other strain with the adhesin inhibited by N-acetyl galactosamine was not (Table
3.8).
3.4 Discussion.
One of the difficulties in identification of host cell receptors for microbial adhesins is
the possibility that the adhesin is binding to an antigen that is adjacent to or co-
purified with the component under investigation. Even if binding of the micro¬
organism can be inhibited with monoclonal antibodies to the putative receptor, there
is always the possibility that the inhibition results from stearic hindrance of the
actual receptor which may be situated very close to the epitope to which the antibody
binds. A more direct method would be to use purified antigen, but at the time the
study was carried out this approach was limited by two practical problems.
Commercially available purified preparations of Lewis3 antigen were very expensive;
therefore, it was not feasible to use these for screening large numbers of strains.
While the antigen can be obtained from secretions by affinity purification with anti-
Lewis3, it is attached to proteins and lipids which may obscure or enhance
interactions with the bacteria.
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The conformation of the antigen binding region of the anti-idiotypic antibodies will
be very similar to that part of the antigen recognised by the monoclonal antibody.
The specificity of the anti-idiotypic antibodies can be confirmed by comparison of
agglutination assays with the monoclonal antibody to which it was produced with
results obtained with monoclonal antibodies to other epitopes on the host cell
surface. The only cross-reactivity observed was with the monoclonal anti-Lewisb
antibody tested. This was expected as the Lewis3 and Lewisb antigens are constructed
on the same precursor chain and the structure of Lewis3 is contained within Lewis'1.
The anti-idiotypic reagent agglutinated a strain of S. aureus and one of C. albicans
which are known to possess surface components that bind to the Lewis3 antigen. C.
albicans GDH 2346 expresses an adhesin that binds fucose, the immunodominant
sugar of Lewis3; and by ELISA, it has been found to bind highly purified Lewis3
antigen [Aly, 1992a,b] and more recently synthetic Lewis3, Lewisb and H type 2
conjugated to biotin [Blackwell, unpublished observations]. Co-agglutination assays
were consistent with this data; strain GDH 2346 was agglutinated but strain GDH
2023, which expresses an adhesin that binds N-acetyl galactosamine [Critchley and
Douglas, 1987] was not.
A major band has been obtained by Synsorb Lewis3 affinity purification of outer
membrane preparations of S. aureus 10655 which was strongly agglutinated by the
anti-idiotypic reagent [Saadi et al., 1994a], While the other S. aureus isolates were
93
also agglutinated by the anti-idiotypic reagent, the possibility that the protein A on
these bacteria was responsible for the observed agglutination of the IgG cannot be
eliminated. More recent studies by other members of the research group have
demonstrated inhibition of binding of S. aureus 10655 using synthetic Lewis3 [Saadi
etal., 1996],
The third objective was to assess the anti-idiotypic antibodies for screening species
for which epidemiological studies have found non-secretors are more susceptible.
The co-agglutination assay was simple and reproducible. The results were useful as a
pilot study to test the hypothesis that anti-idiotypic antibodies might be of value in
overcoming some of the problems associated with specificity of identification of host
cell receptors for micro-organisms and development of new screening reagents for
epidemiological studies. This might be particularly useful for development of new
typing reagents for meningococci. The majority of isolates from patients and carriers
from Greece were not serotypable with the reagents developed for Northwest Europe
and America [Tzanakaki et al., 1993]; but 8/12 of the Greek isolates tested in this
study were agglutinated by the anti-idiotypic reagent. H. influenzae, both typable and
non-typable strains have been isolated from SIDS infants [Telford et al., 1989], The
results obtained here indicate some strains have adhesins that bind Lewis3, however,
studies on frequency of isolation of bacterial species from healthy infants indicate
that H. influenzae is found more frequently in older infants (> 6 months of age)
[Mackenzie et al., 1996; Blackwell et al., submitted for publication].
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Production of monoclonal anti-idiotypic antibodies will be necessary for the
quantities needed for large scale screening and development of more sensitive
detection assays such as ELISA or flow cytometry methods. New methods for the
synthesis of blood group oligosaccharides and production of biotinylated derivatives
at reasonable costs have made the development of anti-idiotypic reagents such as this
less attractive; however, it was useful in complementing the studies indicating the
role of the Lewis3 antigen as a receptor for certain micro-organisms.
The bacterial co-agglutination assay suggests that molecules that bind Lewis3 are
present on strains of several bacterial species to which non-secretors appear more
susceptible than secretors. The anti-idiotypic reagent will be useful in
epidemiological studies to determine if those strains that express the Lewis3 adhesin
are isolated more frequently from patients or carriers who are non-secretors or from
those secretors who express large amounts of Lewis3 [Blackwell et al., 1992, Saadi et
al., 1993], Isolation and characterisation of these adhesins and assessment of their
immunogenicity might lead to new approaches to investigation of pathogenesis of
some of these diseases and their prevention.
In relation to bacterial species isolated from SIDS infants, recent epidemiological
studies have assessed normal nasopharyngeal flora of healthy infants and SIDS
victims [Mackenzie et al., 1996], The predominant isolate among infants in the 0 to 3
month age range was S. aureus (57%) compared with Haemophilus influenzae
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(22%), Streptococcus pyogenes (13%), and Neisseria lactamica (6%). Isolation of
staphylococci was not associated with socio-economic class, maternal smoking or
symptoms of virus infection. Isolation of S. aureus in the Scottish infants and in
Swedish infants [Anainsson et al., 1992] paralleled the peak in expression of the
Lewis3 antigen (Figure 1.3). The isolation rates of these bacteria are mirrored in the
agglutination study: all of the strains of S. aureus tested were agglutinable with the
anti-idiotypic antibody to anti-Lewis3 whereas only 61% of the H. influenzae strains
appeared to bind this antigen.
These observations suggest a parallel with the vulnerability of calves to colonisation
by the enterotoxigenic K99 strains of Escherichia coli. The receptor most avidly
recognised by the adhesins on the E. coli K99, the oligosaccharide N-glycolyl
neuraminic acid a 2-3 galactose, is expressed abundantly in the first weeks of life
during which the calves are susceptible to the diarrhoeal disease caused by these
bacteria. As the expression of the antigen declines, so does the susceptibility to
colonisation and disease [Mouricout et al., 1990],
Currently 60% of SIDS deaths now occur in Britain in the 0 to 3 month age range.
While 56% of healthy infants in this age range were carriers of S. aureus, these
bacteria were isolated from 86.4% of 37 local SIDS infants under 3 months of age
during the period of the studies on healthy infants. Identification of pyrogenic toxins
of S. aureus in over half of the SIDS infants examined [Zorgani et al., 1997]
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complements these epidemiological studies and indicates that further investigation of
the role of toxigenic S. aureus in the events leading to SIDS was warranted.
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CHAPTER 4
Lewis antigen expression on human
monocytes and binding of pyrogenic toxins
4.1 Introduction
There is evidence that Lewis3 and the structurally related Lewisx (CD15) act as
receptors on monocytes for the pertussis toxin of B. pertussis [van t'Wout et al.,
1992], another toxigenic bacterium implicated by epidemiological studies as a cause
of SIDS [Wennegren et al., 1987; Nicoll and Gardner, 1988; Lindgren et al., 1997],
Although there is no evidence that pertussis toxin is present in SIDS infants, both
SECi and TSST-1 have been identified [Newbould et al., 1989; Malam et al., 1992;
Zorgani et al., 1997], These pyrogenic toxins are superantigens which have
significant physiological effects such as induction of fever (>38.5°C), possibly
through direct action on the hypothalamus or through their induction of tumour
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necrosis factor alpha (TNF-a) or interleukin 1 (IL-1). The bacteria produce these
toxins in the temperature range 37 to 40°C, and the amount of toxin produced
increases with the increasing temperature [Bohach et al., 1990]. The actual cause of
a SIDS death might be heat shock reflected by the unusually high temperatures
recorded for some of these infants at autopsy [Sunderland and Emery, 1981], The
increased frequency or duration and depth of sleep due to induction of IL-1 has also
been proposed as a link between respiratory infection and fatal sleep apnoea
[Guntheroth, 1989]. In an animal model it has been demonstrated that sub-clinical
infection with murine lymphocytic choriomeningitis virus can enhance lethality of
SEB, induction of nitric oxide and TNF-a have been implicated in the lethal
responses to the pyrogenic staphylococcal toxins [Sarawar et al, 1994], Nitric oxide
is associated with profound hypotension refractory to vasoconstrictor therapy and
TNF-a with induction of fever via increased prostaglandin synthesis and reduced
myocardial contractility.
The pathological effects of superantigens have been attributed to non-specific
activation of T cells and antigen presenting cells. The proposed mode of action of the
toxins is that they bind to MHC class II antigens of the antigen presenting cells on a
site external to the antigen binding groove and to specific Vp sequences on the T cell
receptor thereby cross-linking the two cell types [Janeway et al., 1989; White et al.,
1989], This study examined the effect of the staphylococcal enterotoxins on
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peripheral blood mononuclear cells rather than T cells to assess the ability of these
toxins to bind to the Lewis3 antigen.
Adherence ofB. pertussis to monocytes by the pertussis toxin (PT) can be reduced by
capping of surface components with some monoclonal antibodies specific for Lewis3
and the structurally related Lewisx. The toxin appears to bind to these fucosylated
polylactosamines, increasing intracellular calcium and acting as a C type lectin [van
t'Wout et al., 1992], Work by Saadi et al. [1993] indicates Lewis3 is a receptor for
toxigenic staphylococci; further evidence for this was obtained in chapter 3.
Oligosaccharides in human milk have been demonstrated to reduce bacterial binding
to epithelial cells [Saadi et al., 1996], Breast feeding is suggested to have a
protective effect against S1DS [Ford et al., 1993]; however, there have been no
studies on the effects these oligosaccharides might have on the staphylococcal toxins
implicated in SIDS, such as TSST-1 [Newbould et al., 1989] and SEQ [Malam et
al., 1992],
The objectives for this part of the project were to determine:
L if the Lewis antigens act as receptors on monocytes for the pyrogenic
staphylococcal toxins;
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2. if the toxins elicit production of nitric oxide which has been implicated in animal
studies on the lethality of staphylococcal enterotoxin B.
3. if the oligosaccharides of Lewis3 and Lewisb can reduce the activity of the toxins.
4.2 Materials and methods
4.2.1 Toxins and antibodies.
The toxins and antibodies used in these experiments are listed in Tables 2.1 and 2.2.
Antibodies used to detect host cell antigens and fluorescein isothiocyanate (FITC)
conjugated antibodies are listed in Table 4.1.
4.2.2 Collection ofmonocytes.
Human peripheral blood monocytes were purified from buffy coats as described in
2.3.2.
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Table 4.1 Antibodies to host cell antigens and FITC-conjugated antibodies.
Antibody Animal source Ie class Supplier
Anti-CD 14 Mouse IgG
Anti-Lewi sa Mouse IgM Scottish
Anti-Lewi sb Mouse IgM Antibody
FITC anti-mouse IgG Rabbit IgG Production Unit
FITC anti-mouse IgM Rabbit IgG (SAPU)
FITC anti rabbit IgG Donkey IgG
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4.2.3 Detection of Lewis8 on monocytes.
Blood samples (20 ml) were obtained from healthy adult volunteers of known
secretor status and the monocytes collected as described in section 2.3.2. To prevent
internalisation of antibodies or toxin the monocytes were diluted to 5 x 105 cells ml"1
and fixed in 1% paraformaldehyde at room temperature for 1 h. The cells were then
washed twice in PBS at 375 x g for 10 min. prior to addition of murine monoclonal
anti-Lewis3 (1/5) (0.5 ml) and incubated at 37°C for 1 h in an orbital shaking
incubator. The cells were washed twice as above and the supernatant discarded. The
monocytes were incubated with FITC conjugated rabbit anti-mouse IgM (1/200) (200
jul) at 37°C for 30 min. as above and washed three times to remove unbound FITC
labelled antibody. The cells were resuspended in 1 ml of 1% buffered
paraformaldehyde and stored in the dark at 4°C prior to reading on an EPICS XL
(Coulter) flow cytometer (4.2.10).
Control samples labelled with anti-CD 14 (SAPU) were used to localise the monocyte
population on the flow cytometer bitmap as small numbers of other cell types are
present after purification. Non-specific binding of the FITC labelled antibody to the
monocyte surface was controlled for using samples containing monocytes, PBS and
FITC conjugated anti-mouse IgG or FITC conjugated anti-mouse IgM.
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4.2.4 Detection of toxins bound to monocytes.
Monocytes (5 x 105) fixed with 1% paraformaldehyde at room temperature for 1 h
were incubated with varying dilutions of the staphylococcal enterotoxins at 37°C for
45 min in an orbital shaker. The cells were washed twice, resuspended in 0.5 ml of
PBS and incubated with 200 pi volumes ofhomologous rabbit anti-toxin at a dilution
of 1/200 for 1 h at 37°C. This dilution was used as preliminary studies had shown
that anti-toxin concentrations above 1/200 resulted in high levels of non-specific
binding. The cells were washed three times and resuspended as above and incubated
for 30 min at 37°C with 200 pi volumes of FITC conjugated donkey anti-rabbit IgG
(1/250) (SAPU).
After washing three times as above, the cells were resuspended in 0.1% buffered
paraformaldehyde (500 pi) and stored in the dark at 4°C until analysed by flow
cytometry on an EPICS XL. Non-specific interaction of rabbit IgG and Fc receptors
on the monocyte surface was controlled by using samples containing monocytes,
PBS and FITC conjugated anti-rabbit IgG.
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4.2.5 Binding of toxins to secretor and non-secretor monocytes.
Human peripheral blood monocytes were isolated from heparinised venous blood
samples (20 ml) taken from healthy adult volunteers within the department, one
secretor and one non-secretor. The monocytes (1 x 106 cells ml"1) were fixed in 1%
buffered paraformaldehyde and incubated for 1 h at 37°C in an orbital shaking
incubator with SEB (Sigma) diluted to 400 and 800 pg ml"1 and the binding assay
outlined above followed. Toxin binding to the two cell populations was assessed by
flow cytometry on an EPICS XL.
4.2.6 Binding inhibition assay.
The following murine monoclonal antibodies were assessed for their ability to inhibit
binding of the staphylococcal toxins to monocytes: anti-Lewis3 (1/5) and anti-Lewisb
(1/5). The fixed monocytes were incubated with 200 pi volumes of antibody for 60
min at 37°C. The cells were washed twice to remove unbound antibody and the
binding assay for the toxins outlined above followed. The cells were then assessed by
flow cytometry.
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4.2.7 Monocyte challenge assay.
The monocyte suspension (0.5 ml of 2 x 106 cells ml"1) in DMEM with additives plus
15% FCS (2.3.1) was added to the wells of a 24 well tissue culture plate (Greiner). A
time course experiment was carried out with monocytes challenged with varying
concentrations of SEB to determine the optimum incubation time for production of
nitric oxide. The culture supernatants were sampled at 24 hour intervals over a
period of 4 days and assayed for nitrite content.
Preliminary dose response experiments were carried out to ascertain the optimum
toxin concentration for induction of nitric oxide. The staphylococcal toxins SEA,
SEB, SEC] and TSST-1 were diluted in DMEM without additives to concentrations
of 0.05, 0.25, 0.5, and 2.5 pg ml"1. The monocytes were then challenged with 0.5 ml
of dilutions of the staphylococcal toxins (2.4.1). The cells were incubated for 72 h
(Table 4.3) at 37°C in 5% CC>2- The culture supernatants were removed and
centrifuged at 1,250 x g for 10 mins to remove any remaining cells prior to
determination of nitrite content.
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4.2.8 The effect of pre-treatment with the Lewis antigens on TSST-1
induced nitric oxide production.
TSST-1 was diluted in DMEM with no additives to give a working concentration of
2 ug ml"1 and incubated overnight at 37°C in an orbital shaker with equal volumes of
either synthetic Lewis3 or Lewisb (50 jug ml"1) (Dextra Labs), Lewis antigen
concentrations were set in excess of those used in other blocking studies [Saadi,
personal communication] to ensure saturation of binding sites on TSST-1. The
toxin/Lewis antigen mixtures were then used in the monocyte challenge assay to
determine whether or not the Lewis antigens were capable of blocking the bioactivity
of TSST-1. The toxin/Lewis antigen mixtures (0.5 ml) were added to the monocyte
suspension (0.5 ml) and incubated as described above.
4.2.9 Assay for nitric oxide production.
This assay, modified from Zhang et al., [1994], was used to determine the amount of
nitric oxide produced by monocytes in response to toxin challenge by measuring the
levels of its stable breakdown compound nitrite (2.5.1).
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4.2.10 Flow cytometry.
Flow cytometric analysis of cells was performed using an EPICS XL flow cytometer
(Coulter). Cell populations were selected from the bitmap to exclude fragmented
cells and any contaminating (non-monocyte) cell types remaining after Ficoll-
hypaque separation of monocytes from buffy coats. The bitmap displays the sample
population as forward angle light scatter versus 90° light scatter allowing
differentiation of cell size and relative granularity among the population. Background
fluorescence was blanked using control samples containing untreated cells plus
fluorescent antibody. The percentage of cells in test samples showing fluorescence
greater than background was assessed as a single parameter histogram measuring
fluorescence on a logarithmic scale. Mean channel fluorescence values of the
positive cells were multiplied by percentage of positive cells to give the binding
index (BI).
4.2.11 Statistical methods.
Data are represented as the mean and standard deviation of the replicate experiments.
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4.3 Results
4.3.1 Detection of Lewis3 on human monocytes.
The binding indices for anti-Lewis3 to fixed monocytes from secretors (S) (n=3) and
non-secretors (NS) (n=3) are shown in figure 4.1.The average binding index
observed of anti-Lewis3 to non-secretor cells was 3 times that of secretor cells.
4.3.2 Binding of staphylococcal toxins to human monocytes.
Figures 4.2 to 4.5 show the binding of dilutions of the staphylococcal enterotoxins
SEA, SEB, SEC] and TSST-1 to human monocytes. All of the toxins bound to the
monocytes in a dose dependant manner. The data were used to determine the
optimum toxin concentration of SEA 0.5 pg ml"1, SEB 1 pg ml"1, SEQ 20 pg ml"1
and TSST-1 20 pg ml"1 for use in the binding inhibition experiments with antibodies
to the Lewis antigens. All samples tested were from secretors expressing Lewis3 and
Lewisb, determined by agglutination of erythrocytes by blood grouping antibodies to
Lewis3 and Lewisb prior to purification of the monocytes (n=4) (data represents the




Figure 4.1 Binding of anti-Lewisa to secretor (S) and non-secretor (NS) monocytes.
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Figure 4.2 Binding of SEA to monocytes.
Figure 4.3 Binding of SEB to monocytes.
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Figure 4.5 Binding ofTSST-1 to monocytes.
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4.3.3 Binding of SEB to secretor and non-secretor monocytes.
To elicit a clear difference in toxin binding levels to secretor and non-secretor
monocytes the concentration of toxin used had to be greatly increased. Given the
relatively small amounts of SEA, SEC] and TSST-1 available and their cost, it was
only feasible to carry out this part of the project using SEB supplied by Sigma. In 2
experiments with 1 non-secretor donor and 1 secretor donor the toxin showed
increased binding to the non-secretor fixed cell population (NS) (n=l) (binding index
for anti-Lewis3=729.8) which expressed higher levels of the Lewisa antigen than the
secretor (S) (n=l) (binding index for anti-Lewisa=175.4) population at both 400 and
800 pg ml"1, an increase of 114.37% and 133.38% respectively (Figure 4.6).
Although the increase in binding of toxin to non-secretor cells compared with
secretor cells is not as marked as the increase in binding of anti-Lewis3. There was a







Figure 4.6 Binding of SEB to monocytes from a secretor (S) and a non-secretor
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Figure 4.7 Binding of staphylococcal toxins to monocytes pre-treated with
antibodies to the Lewis antigens.
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4.3.4 Inhibition of toxin binding by antibodies to the Lewis antigens.
In 4 experiments using fixed cells, pre-treatment of monocytes with anti-Lewis3 or
anti-Lewisb caused the greatest reduction in binding of SEC] (20 pg ml"1) (70.93%
and 66.21% respectively), the level of TSST-1 (20 pg ml"1) binding was also
reduced, though to a lesser extent (50.94% and 39.63% respectively). Binding of
SEA (0.5 pg ml"1) was greatly increased on the monocytes incubated with anti-
Lewis3 and anti-Lewisb (168.43% and 213.21% respectively), the binding index for
SEB (1 pg ml"1) remained similar in both control and test samples (non-significant),
this result does not support the findings of the binding assay for SEB to secretor and
non-secretor monocytes. All samples tested were from secretor donors (n=8)
expressing both Lewis3 and Lewisb (Figure 4.7).
4.3.5 Production of nitric oxide in response to staphylococcal toxins.
Increased nitric oxide levels were detectable in all of the SEB challenged samples
except the most concentrated (10 pg ml"1) by 48 h. All samples showed moderate to
high nitric oxide production by 72 h, the 96 h sample results were similar to those at
72 h. The incubation time for further experiments was 3 days. The peak of nitric
oxide production from the monocytes probably occurs between 2 and 3 days with the
higher levels in the 72 h sample indicating accumulation of nitrite molecules in the
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culture supernatant rather than a delayed response as nitric oxide levels had reached
a plateau by 96 h (Table 4.3).
The monocyte challenge assay was used with a range of dilutions of the 4
staphylococcal toxins to determine the optimum concentration of each toxin for
induction of nitric oxide. The nitrite levels in test samples were obtained from the
optical density of the sample read from the standard curve controls for each
experiment (Figure 4.8). Challenge with the staphylococcal toxins was shown to
induce production of nitric oxide from human monocytes in a dose dependent
manner though the higher toxin concentrations (above 1 pg ml"1) showed lower
levels of nitric oxide production. This appeared to be due to the cells dying as cell
viability was found to be reduced in these wells. All of the toxins induced similar
levels of nitric oxide though the actual amounts produced varied with each monocyte
sample. The data in table 4.4 represents the results of experiments with monocytes
from 10 different donors.
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nM NaN02
Figure 4.8 NaN02 standard curve.
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Table 4.3 nM NO response to staphylococcal enterotoxin B challenge by monocytes
over a 96 hour time course. (Standard deviation figures in brackets. Data
are the mean of 4 experiments).
24 hours 48 hours 72 hours 96 hours
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Table 4.4 Nitrite production at 72 hours in response to increasing concentrations of
SEA, SEB, SEC! and TSST-1. (Mean of 10 donors).
Mean
Toxin nM NO S.D.
SEA
2.5 pg ml"1 0.187 0.0143
0.5 pg ml"1 0.232 0.0229
0.25 pg ml"1 0.199 0.0172
0.05 pg ml"1 0.164 0.0143
SEB
2.5 pg ml"1 0.160 0.0172
0.5 pg ml" 0.257 0.0143
0.25 pg ml"1 0.199 0.0257
0.05 pg ml"1 0.166 0.0200
SEC,
2.5 pg ml"1 0.212 0.0300
0.5 pg ml"1 0.259 0.0386
0.25 pg ml"1 0.194 0.0358
0.05 pg ml"1 0.160 0.0314
TSST-1
2.5 pg ml"1 0.186 0.0172
0.5 pg ml"1 0.217 0.0272
0.25 pg ml"1 0.204 0.0229
0.05 pg ml"1 0.187 0.0329
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Figure 4.9 Nitric oxide induction by TSST-1 in the presence and absence of
synthetic Lewis3 and Lewisb (data expressed as nM NO produced).
121
4.3.6 Effect of Lewis antigens on induction ofnitric oxide by TSST-1.
In experiments with monocytes from 8 different donors, the ability of TSST-1 (0.5
pg ml"1) to induce production of nitric oxide from monocytes was reduced by pre-
treatment of the toxin with the Lewis" antigen (12.5 pg ml"1) (42.36% reduction from
TSST-1 control level), the structurally related Lewisb antigen caused an increase in
TSST-1 bioactivity of 78.47%. The Lewis3 control stimulated a higher level of nitric
oxide production than the TSST-1 control (an increase of 59.27%) (figure 4.9).
4.4 Discussion
4.4.1 Utilisation of the Lewis antigens as binding sites by the
staphylococcal enterotoxins.
It is known that the pertussis toxin of B. pertussis uses the Lewis3 and structurally
related Lewisx antigens as cell surface receptors on human monocytes [van fWout el
al., 1992], The first objective of this part of the study was to determine if the
staphylococcal enterotoxins could utilise the Lewis antigens in a similar way. The
flow cytometric assays for binding and inhibition of binding of the toxins by
monoclonal antibodies to the Lewis antigens showed that all of the toxins bound to
the surface of monocytes, and at the concentrations used, the binding of SEC] and
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TSST-1 could be reduced by the antibodies to the Lewis antigens, the increased
binding of SEA to anti-Lewis3 and anti-Lewisb treated cells may be the result of
either a conformational change in cell surface receptors caused by binding of the
antibodies or an epitope of the antibodies themselves providing a binding site for the
toxin. The apparent correlation between binding of SEB at high concentrations (400
and 800 pg mf1) and expression of Lewis3 was not observed in the inhibition assay
when the cells were treated with anti-Lewis3 and anti-Lewisb, this may have been due
to the greatly reduced quantities of toxin used (1 pg mf1). Studies by Malam et al.,
1992 and Newbould et al., 1989, both using fixed human kidney samples, found SEC
and TSST-1 in significantly higher percentages of SIDS victims compared with
controls (SEC 36%, TSST-1 18%, both SEC and TSST-1 8%). SEA, SEB and SED
were not found in the kidney samples [Malam et al., 1992], Co-production of SEC
and TSST-1 is common in strains of S. aureus affecting humans [Bohach et al.,
1990],
4.4.2 Induction of nitric oxide from monocytes by pyrogenic toxins.
The staphylococcal toxins caused induction of nitric oxide from monocytes in a dose
dependant manner though a decrease in NO production was observed at the highest
toxin concentration, this could have resulted from the cells dying prior to mounting
an inflammatory response.
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4.4.3 Effect of the Lewis antigens on induction of nitric oxide by
TSST-1.
The third objective was to determine if induction of nitric oxide from monocytes by
TSST-1 was affected by reducing the number of available Lewis antigen binding
sites on the toxin by pre-treatment with synthetic oligosaccharides of Lewis3 and
Lewisb. Although the synthetic oligosaccharides were capable of stimulating
production of nitric oxide on their own, a marked decrease was observed in the
ability of TSST-1 to induce nitric oxide production when the toxin was treated with
synthetic Lewis3. This could be interpreted as additional evidence that the toxin is
capable of using this antigen as a binding site. Despite sterile conditions and aseptic
procedure used in the preparation of the TSST-l/Lewis antigen mixtures, the
increase in nitric oxide production in response to the synthetic Lewis3 antigen could
have been due to contamination of the sample, though this was not seen in the cells
treated with both Lewis3 and TSST-1. Another explanation for this is that binding of
the TSST-1 to the synthetic Lewis3 covered the stimulatory epitope on the
oligosaccharide. Synthetic Lewis appeared to enhance the effect of TSST-1. Further
work is required to compare the effects of natural and synthetic oligosaccharides of
the Lewis antigens on the staphylococcal toxins to clarify this point.
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Because there appeared to be sites on the pyrogenic toxins that bind Lewis3, the




Antigenic cross-reactivity among bacterial
toxins and the protective effect of infant
immunisation
5.1 Introduction
Results in chapter 4 indicated that some of the pyrogenic staphylococcal toxins
might, like the pertussis toxin, use Lewis3 as a receptor on monocytes. This led to the
hypothesis that the apparent protective effect of immunisation with the diphtheria,
pertussis, tetanus (DPT) vaccine in relation to SIDS could be due to the presence of
similar epitopes on the staphylococcal toxins and pertussis toxin.
Although it was suggested that DPT immunisation was associated with SIDS [Baraff
et al., 1983], epidemiological studies in the United States demonstrated that
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unimmunised infants or infants immunised late were at increased risk of SIDS
[Hoffman et al., 1987; Walker et al., 1987], an increase in SIDS deaths was also
noted in Sweden when pertussis immunisation was discontinued [Wennegren et al.,
1987], It has been suggested that some SIDS deaths could be due to asymptomatic
whooping cough, if so immunisation would help reduce these deaths.
Although the decline in cot deaths in Britain has been attributed to the campaign
started in October 1991 to reduce the prone sleeping position, there was a major
change in infant health care practice that affected all infants and predated the "back
to sleep" campaign by a year. In October 1990 the infant immunisation schedule was
changed to begin at 2 months rather than 3 months. This change appears to coincide
with the beginning of the decline in SIDS deaths in Britain. If DPT immunisation
played a role in reducing SIDS deaths, it was predicted that there would be a shift in
the age range with a decline in the proportion of SIDS deaths occurring in the post-
immunisation group (>2 months).
The objectives of the study were:
I. to assess cross-reactivity between the staphylococcal enterotoxins and
PT ofB. pertussis using polyclonal antisera to the enterotoxins;
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2. to determine if immunisation with the DPT vaccine induced antibodies that
bound to staphylococcal enterotoxins;
3. to determine if pre-incubation with polyclonal anti-DPT could reduce the
inflammatory effects of the staphylococcal toxins on human monocytes;
4. to assess the age distribution of SIDS infants before and after the changes
in infant immunisation schedules.
5.2 Materials and Methods
5.2.1 ELISA reagents.
The toxins, antitoxins and reagents for the direct and sandwich ELISA protocols are
listed in 2.1 and 2.2.
5.2.2 Direct ELISA for detection of toxins.
The direct ELISA to detect the toxins was a two step method in which the toxins
were diluted in PBS (2.2.1.2) at pH 8 and bound directly to the wells of a 96 well
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ELISA plate (Immulon II, Dynatech). The plate was incubated overnight at 4°C,
washed six times with washing buffer (2.2.1.3) on a Dynatech microtitre plate
washer, dried and blocked with blocking buffer (2.2.1.4) to reduce non-specific
binding. The anti-toxins were diluted in blocking buffer, added to the plate and
incubated at 37°C for 45 min. The plate was washed six times and dried. Horseradish
peroxidase (HRP) conjugated anti-IgG specific for the species in which the anti-toxin
was produced was diluted in blocking buffer and added to the wells (100 pi). The
plate was incubated at 37°C for 45 min as above, washed eight times and dried. The
OPD substrate (2.2.1.6) (100 pi) activated with hydrogen peroxide was added to all
of the wells and the plate incubated in the dark for 15 minutes to allow colour to
develop. The enzymatic reaction was stopped with of 12.5% (v/v) sulphuric acid
(50pl) and the plate read at 492 nm on a Dynatech MR 700 plate reader. Negative
control wells contained PBS, blocking buffer and HRP conjugated antibody.
5.2.3 Sandwich ELISA for detection of toxins.
The polyclonal capture antibody was diluted in coating buffer and distributed in 100
pi volumes into a 96 well ELISA plate. The plate was incubated at room temperature
for 2 hours or at 4°C overnight and the primary antibody removed The plate was
washed three times and dried. Blocking buffer (100 pi) was added to the wells and
the plate incubated at room temperature for 30 min before removing the blocking
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buffer and blotting dry. The toxins were diluted in blocking buffer and added to the
appropriate wells (100 pi). The plate was incubated at 37°C in an orbital incubator
for 45 min before being washed three times to remove unbound antigen and blotted
dry. The HRP conjugated antitoxin was diluted in blocking buffer and added to the
wells (100 pi). The plate was incubated at room temperature for 2 h or at 4°C
overnight before being washed six times and dried as above. The OPD substrate was
added and the experiment carried out as in 5.2.2.
5.2.4 Polyacrylamide gel electrophoresis.
The purity of the toxins obtained from Toxin Technology Inc. and Sigma was
assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS
PAGE) using the method of Laemmli [1970] (2.7.2) to ensure that any cross-
reactivity was not the result of any other toxin or toxin fragment being co-purified
with the named toxin.
Toxin samples were diluted to 200 pg ml"1 except for the pertussis toxin (Sigma)
which was left undiluted as the supplied stock concentration was only 50 pg ml"1.
The toxin samples were mixed 1:1 with sample buffer (2.7.3.1) and denatured by
heating to 100 °C for 10 min. The samples were then placed in the 4% stacking gel
(2.7.1.5) wells in 20 pi volumes and run at a constant 60 V until they reached the
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interface with the 12% separating gel (2.7.1.5). The constant voltage was increased
to 150 V until the dye front had migrated to within 30 mm of the bottom of the gel.
The gel was then removed and the toxins stained for using the Coomassie blue
staining procedure (2.7.4).
5.2.5 Direct ELISA for cross-reactivity among toxins.
The polyclonal antisera above and an antiserum to SEB (Sigma) at a dilution of
1/100 in blocking buffer were used in an ELISA to assess the degree of cross-
reactivity among several bacterial toxins. The following toxins were bound to 96
well microtitre plates in PBS (pH 8) overnight at 4°C: SEB (Sigma),SEA, SEC and
TSST-1 (Toxin Technology) (0.5 pg ml"1); PT (Sigma) (2pg ml"1); endotoxin of E.
coli (026:B6) (Sigma) (lpg ml"1). The plates were blocked with blocking buffer for
30 min at room temperature. The antisera (lOOpl) were added and the plate
incubated at 37°C in an orbital shaker for 1 h. The plates were washed three times
with washing buffer, and E1RP conjugated sheep anti-rabbit IgG (1/200) was added
and incubated overnight at 4°C. The plates were washed six times, the OPD substrate
added and the plates read as described above (5.2.2). Negative controls were as
above (5.2.2).
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Cross-reactivity with heterogeneous toxins was expressed as a percentage of the
optical density value of each toxin with its homologous antitoxin (100%). Values >
100 were judged to be evidence of cross-reactivity.
5.2.6 Detection of cross-reactivity among toxins by the sandwich
ELISA system.
The results of the direct ELISA system (5.2.4) were compared with those of a
sandwich ELISA. The plates were coated overnight at 4°C with rabbit polyclonal
antisera to SEA, SEB, SEC and TSST-1 diluted 1/100 in coating buffer. The plates
were blocked with blocking buffer for 1 h at room temperature. The toxins, SEA,
SEB, SEC, TSST-l(Toxin Technology), PT (Sigma) (0.5 pg ml"1) or LPS (Sigma)
(2.5 jug ml"1) were added and the plates incubated at room temperature for 90 min.
The plates were washed three times and HRP conjugated rabbit anti-SEA, SEB, SEC,
and TSST-1 IgG (1/100) was added. The plates were incubated for 2 h at 37°C and
washed six times prior to the addition of the OPD substrate. The plates were read as
before and the results expressed as in 5.2.4. Negative control wells contained the
capture antisera, blocking buffer and the HRP conjugated antisera.
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5.2.7 Production of rabbit anti-DPT serum.
A female New Zealand White (NZW) rabbit was inoculated sub-cutaneously with 5
doses (0.5 ml) of DPT vaccine (Evans) at 1 month intervals. The vaccine contains
toxoids of diphtheria, pertussis and tetanus and chemically killed whole cell B.
pertussis. The rabbit was bled 7 days after the final boost and the serum separated by
centrifugation at 1,250 x g for 20 min. The immune serum was stored at -20°C prior
to use. Non-immune serum was obtained from the rabbit prior to immunisation and
stored under the same conditions.
5.2.8 Detection of antibodies to DPT by ELISA.
Normal rabbit serum and serum from the immunised rabbit were tested in an ELISA
system in which 96 well microtitre plates were coated with DPT vaccine diluted 1/40
in coating buffer overnight at 4°C. The plates were washed three times and blocked
for 30 min at room temperature with blocking buffer. The serum from the immunised
rabbit was diluted in blocking buffer (1/20, 1/50, 1/100, 1/200, 1/400), added to the
plate and incubated at 37°C in an orbital shaker for 1 h. After washing three times,
HRP conjugated sheep anti-rabbit IgG (1/200) in blocking buffer was added, the
plates were incubated overnight at 4°C and washed six times prior to addition of
OPD for 10 min in the dark at room temperature. The reaction was
133
stopped with 12.5% H2SO4 and read at 492 nm. The test was compared with
identical dilutions of serum obtained from the rabbit prior to immunisation and
normal rabbit serum from SAPU. Negative control wells contained the test or control
sera plus HRP conjugated sheep anti-rabbit IgG.
5.2.9 Whole cell ELISA with B. pertussis.
The whole cell ELISA method described by Abdillahi and Poolman [1988] for typing
N. meningitidis was adapted for this study. A fimbriate type 1,2 strain of B. pertussis
8002 (supplied by Dr. N.W. Preston, Manchester University) was used in these
experiments. Wells ofELISA plates were coated with 100 pi volumes of B. pertussis
(4 x 109 mT1) in coating buffer for 48 h at 4°C. The plates were washed three times
and blocked with blocking buffer for 30 min at room temperature. The polyclonal
antisera to the staphylococcal enterotoxins were diluted (1/50, 1/100, 1/200 and
1/250) in blocking buffer, added to the plates and incubated at 37°C for 1 h. The
plates were washed three times prior to overnight incubation at 4°C with HRP
conjugated anti-rabbit IgG. The plates were washed six times and the substrate added
to the plates for 10 min. The reaction was stopped with 12.5% H2SO4 and the plates
read at 492 nm. Control wells contained antisera to the staphylococcal toxins without
bacteria and bacteria with only HRP conjugated anti-rabbit IgG.
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5.2.10 Binding ofB. pertussis typing serum to PT and the
staphylococcal toxins.
The direct ELISA for detection of toxins (5.2.2) was modified to assess the binding
of B. pertussis typing serum (Difco) to PT and the staphylococcal toxins. The plates
were coated overnight at 4°C with the toxins diluted to 0.5 pg ml"1 in PBS (pH 8).
The plates were blocked with blocking buffer for 30 min. at room temperature.
Doubling dilutions of the B. pertussis typing serum (1/50 to 1/400) were added to the
wells and the plates incubated at 37°C for 45 min. The plates were washed six times
and dried. HRP conjugated anti-rabbit IgG diluted to 1/100 in blocking buffer (100
pi) was added to the wells and the plate incubated at 37°C for 45 min. as above. The
plates was washed eight times and dried prior to addition of the substrate. The
enzymatic reaction was stopped after 15 min. with 50 pi of 12.5% sulphuric acid and
the plate read at 492 nm as above (5.2.2). Negative control wells contained either
toxin, blocking buffer and HRP conjugated anti-rabbit IgG or blocking buffer, typing
serum and HRP conjugated anti-rabbit IgG.
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5.2.11 Neutralisation of toxin bioactivity using antibodies to TSST-1
and the DPT vaccine.
The monocyte challenge assay (2.4) was modified to assess the ability of rabbit
polyclonal anti-TSST-1 (Toxin Technology) and the polyclonal antiserum raised to
the DPT vaccine to neutralise the bioactivity of the staphylococcal enterotoxins. The
toxins were diluted in DMEM with no additives to a working concentration of 4 pg
ml"1 and incubated overnight at 37°C with equal volumes of polyclonal anti-TSST-1
(1/100) in DMEM or serum from the rabbit immunised with DPT (1/50) in DMEM.
Pre-bleed serum (1/50) in DMEM was used as a negative control. The toxin/antibody
mixtures were added in 0.5 ml volumes to the wells of a 24 well tissue culture plate
containing 1 x 106 monocytes in 0.5 ml of DMEM with additives plus 15% FCS to
give a final dilution of 1 pg ml"1 toxin and 1/400 anti-TSST-1. The plates were
incubated for 3 days at 37°C in a 5% C02 atmosphere. The culture supernatants were
centrifuged at 1,250 x g for 10 min to remove cellular debris and stored at -20°C
prior to determination ofnitric oxide content.
The level of neutralisation was calculated as the percentage decrease in NO




The data are represented as the mean and standard deviation of the replicate
experiments. The X test for trend was used to assess changes in age distribution
among SIDS infants between 1988 and 1994. Data for the South East of Scotland
was provided by the Scottish Cot Death Trust.
5.3 Results
5.3.1 Assessment of toxin purity.
The SDS polyacrylamide gels run to assess the purity of these toxin samples showed
clear major bands for all four of the toxins. Very faint secondary bands were
observed just below the SEB and SEQ bands. Only one band was visible in the SEA
and TSST-1 samples. Molecular mass markers were not run with the gels as the
masses of the staphylococcal enterotoxins are well documented [Johnson et al.
1991]; however, the relative positions on the gel of the toxin bands conformed to
their relative molecular masses: SEA (27.8 kDa); SEB (28.3 kDa); SEC! (26.0 kDa);
TSST-1 (24.0 kDa). Pertussis toxin (Sigma) was also run but at a lower concentration
(25 pg ml"1) due to the concentration of the original stock solution
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being less than that of the Toxin Technology samples (100 pg ml"1). The pertussis
toxin sample produced 3 very faint bands, the middle band being of a similar
molecular mass to TSST-1 (24 kDa) (figure 5.1).
5.3.2 Binding of antisera to toxins assessed by ELISA.
The results of 6 experiments in which the toxins were bound directly to the ELISA
plate are summarized in Table 5.1. Anti-SEA showed significant cross-reactivity
with TSST-1. Anti-SEC] showed significant cross-reactivity with SEB. No
significant cross-reactivity was observed with other heterologous toxin/antitoxin
combinations. None of the anti-toxins produced values greater than 100 in assays
with endotoxin. For PT the only anti-toxin with O.D. values similar to those for the
homologous toxin was anti-TSST-1.
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SEA SEB SECi TSST-1 PT
Figure 5.1 SDS polyacrylamide gel electrophoresis to ascertain the purity of the
staphylococcal enterotoxins and pertussis toxin stained with Coomassie
brilliant blue.
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Table 5.1 Cross-reactivity of the staphylococcal enterotoxins, pertussis toxin and
lipopolysaccharide expressed as % O.D. of toxin plus homologous






Toxin Mean % Range S.D.
SEA 100.0 - -
SEB 107.1 52.6-211.1 55.7
SEC 73.9 45.7-96.4 22.7
TSST-1 114.2 96.4 - 125.6 12.1
PT 63.3 17.2-92.3 28.1
LPS 39.2 24.4-99.8 26.3
SEB 100.0 - -
SEA 70.0 44.4 - 140.0 37.9
SEC 71.8 22.9- 157.5 47.6
TSST-1 78.9 44.2 - 167.5 47.3
PT 46.3 17.7-89.0 27.5
LPS 49.7 26.2 -99.1 26.5
SEC 100.0 - -
SEA 97.6 70.0 - 107.3 38.3
SEB 245.0 65.0-339.8 114.6
TSST-1 124.9 87.3 - 168.6 30.5
PT 77.6 33.3 - 125.0 33.7
LPS 80.4 26.2 - 140.0 39.7
TSST-1 100.0 - -
SEA 114.8 32.7- 188.0 59.1
SEB 120.5 47.1 - 187.0 49.1
SEC 82.7 40.4- 148.0 38.8
PT 108.2 62.0 - 164.0 45.4
LPS 79.6 32.0 - 172.0 50.4
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5.3.3 Sandwich ELISA.
The results of 6 experiments using the sandwich ELISA system are summarised in
Table 5.2. With this method no cross-reactivity was detected. The only antibodies
binding a non-homologous toxin to any degree were anti-SEB with SECj (37.18%)
and anti-SECi with SEB (5.78%), for which the greatest binding was observed in the
direct ELISA. No reaction was observed between pertussis toxin or LPS and any of
the antisera to the staphylococcal enterotoxins.
5.3.4 Binding of anti-DPT antiserum to the DPT vaccine and the
staphylococcal toxins.
The OD value obtained for anti-DPT at a dilution of 1/100 and the vaccine used to
immunize the rabbit was taken as 100%. Binding of non-immune rabbit sera to the
toxins was minimal with OD readings similar to that of the wells containing coating
buffer alone (1.2 to 4.5%). Figure 5.2 summarizes the results as the means of 6
experiments. OD values for binding of the immune rabbit serum to the
staphylococcal toxins was at least 60% that of binding to the vaccine at a dilution of
1/100 and the highest binding was observed for TSST-1 (104.19% and 53.25% at
antibody dilutions of 1/100 and 1/200 respectively).
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Table 5.2 Cross-reactivity of the staphylococcal enterotoxins, pertussis toxin and
LPS by sandwich ELISA. (Data are mean of 6 experiments expressed as
% O.D. of toxin plus homologous anti-toxin).
SEA SEE SEC, TSST-1 PT LPS
Anti-SEA 100.0 .....
Anti-SEB - 100.0 37.18





5.3.5 Binding of staphylococcal anti-toxins to B. pertussis.
The antisera to the staphylococcal toxins were examined in the whole cell ELISA
with B. pertussis to determine if binding to the DPT vaccine was due to cross-
reactive antigens on the surface of B. pertussis. The OD value obtained with the B.
pertussis typing serum at a dilution of 1/50 was taken as 100%. Figure 5.3
summarizes the results of 6 experiments. Among the antisera to the staphylococcal
toxins, the antiserum to SEC| showed the greatest binding (86.8% at 1/200); the
other antisera also showed moderate to high levels of binding. There was a steady
decrease in binding of anti-TSST-1 to the bacteria with increasing dilution of the
antiserum.
5.3.6 Binding of the B. pertussis typing serum to PT and staphylococcal
toxins.
Figure 5.4 summarizes the results of 5 experiments. The O.D value at 492 nm
obtained for binding of the typing serum at a dilution of 1/50 to PT was taken as
100%. At a dilution of 1/50, the highest binding of the typing serum was obtained
with the PT. At higher dilutions, binding of anti-B. pertussis typing serum was
greatest with SEA at 1/100 (72.07%) and with SEB at dilutions of 1/200 and 1/400











Figure 5.2 Binding of serum from a rabbit immunised with DPT to the
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Figure 5.3 Binding of antiserum to the staphylococcal toxins to whole cell








Figure 5.4 Binding ofB. pertussis typing serum to pertussis toxin and the
staphylococcal toxins. Binding of the serum to pertussis toxin was used
as the positive control (100%).
146
5.3.7 Neutralisation of the staphylococcal enterotoxins with
anti-TSST-1.
The results of 6 experiments are summarised in figure 5.5. The level of nitrite
obtained with toxin alone was taken as 100%. The levels of nitrite obtained with the
toxins treated with anti-TSST-1 (1/400) were expressed as the percentage of their
respective controls. With the exception of SEC] all of the staphylococcal
enterotoxins showed a reduction in their ability to induce production of nitric oxide
from human monocytes when pre-incubated with polyclonal anti-TSST-1. The
neutralising effect of the antibody was greatest with its homologous toxin (26.29%
reduction) though it showed only a minor reduction in the bioactivity of SEC!
(1.05% reduction). SEA and SEB activities were reduced by 16.39% and 23.40%
respectively.
5.3.8 Neutralisation of the staphylococcal enterotoxins with anti-DPT.
The results of 4 experiments are summarised in figure 5.6. The polyclonal antiserum
to the DPT vaccine was used at a dilution of 1/50, rather than 1/100 as used in the
ELISA to maximise any neutralising effect on the toxins, it reduced the ability of the
toxins to induce nitric oxide production. The greatest reduction was again observed
with TSST-1 (52.65%) though all of the toxins showed higher levels of neutralisation
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than with anti-TSST-1, SEA (17.12%), SEB (36.61%) and SEC! (30.84%). The
normal rabbit serum showed no ability to neutralise the effects of the staphylococcal
toxins. The antibody alone controls (monocytes plus anti-TSST-1 and monocytes
plus anti-DPT) showed very little activity above baseline nitric oxide levels produced
by monocytes in the medium alone.
5.3.9 Age distribution of SIDS infants following changes in the DPT
immunisation schedule.
The number of SIDS deaths in Scotland from 1980-1994 is shown in figure 5.7 (data
supplied by the Scottish Cot Death Trust). The incidence showed little fluctuation
over the decade until 1990-91 when there was a sharp drop in the number of cot
deaths. Table 5.3 shows the age distribution of SIDS cases in southeast Scotland
(Lothian, Borders and Fife regions). Although there has been a decrease in the total
number of SIDS deaths since 1990, the proportion of infants aged 2 months or less
has increased from 11% in 1988 to 56% in 1994 (P<0.001).
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Figure 5.5 Neutralisation of the staphylococcal toxins using monoclonal
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Figure 5.6 Neutralisation of the staphylococcal toxins using a rabbit polyclonal
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Figure 5.7 SIDS incidence in Scotland, 1980-1995.
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Table 5.3 Age distribution of SIDS cases in southeast Scotland.




1988 28 3 (10.7) 25 (89.3)
1989 38 6 (15.8) 32 (84.2)
1990 40 12 (30) 28 (70)
1991 17 4 (23.5) 13 (76.5)
1992 13 5 (38.5) 8 (61.5)
1993 17 7 (41.2) 10 (58.8)
1994 16 9 (56.3) 7 (43.6)
X2 test for trend = 14.37, P<0.001.
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5.4 Discussion
5.4.1 Cross-reactivity between toxins.
The first objective of the study was to assess cross-reactivity among staphylococcal
toxins and pertussis toxin as it and the staphylococcal toxins appear to have epitopes
that bind the Lewis3 antigen [van t'Wout et al., 1992; chapter 4], The findings of
cross-reactivity in the direct ELISA between the staphylococcal enterotoxins are
supported by evidence of similarities in their sequence and structure which indicates
that they fall into two groups: SEA, SED and SEE make up one group; SEB, SECt
and SEC3 form the other [Marrack and Kappler, 1990], It is known that the members
of both groups share a high amino acid sequence homology: SEA, D, E >90%
[Marrack and Kappler, 1990]; SEB, SEC, 65% [Johnson et al., 1991], TSST-1
exhibits a secondary structure similar to that of the other staphylococcal enterotoxins
(low a-helix and high P-pleated sheet content) [Chou and Fasman, 1973], the
published three-dimensional structures of SEB and TSST-1 [Swaminathan et al.,
1992 and Sridhar Prasad et al., 1993] also show similarities, though TSST-1 shares
little primary sequence with the other staphylococcal superantigens (40-45%)
[Micusan and Thibodeau, 1992],
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The degree to which polyclonal anti-.fi. pertussis binds epitopes on the
staphylococcal enterotoxins appears to depend on the concentration of the antibody.
Its binding most to SEB at higher dilutions suggests that it is most cross-reactive with
this toxin rather than with SEA; however, it is possible that different components of
the antiserum are recognising different epitopes on the toxins. Throughout the range
of dilutions, the antiserum to SECi was found consistently to produce the highest
O.D. values of the antisera to the staphylococcal toxins with whole cell fi. pertussis
(Figure 5.3).
5.4.2 Comparison ofELISA techniques.
The differences found between the direct and sandwich ELISA techniques for
detection of antibody cross reactivity do not agree with the findings of Fey et al.
[1984] whose comparisons of different ELISA systems for the detection of single
staphylococcal toxins in food samples found the double-antibody sandwich technique
to be superior to other versions of the ELISA. The higher levels of cross-reactivity
detected by the direct ELISA is not an artifact of non-specific binding as negative
control levels were similarly low in both systems. Agreement was seen between the
two ELISA systems in showing cross reactivity between SEB and SEC] (Tables 5.1
and 5.2). The results of the direct ELISA are also supported by the observed
neutralisation of the staphylococcal toxins by anti-TSST-1 and the
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antiserum to DPT (Table 5.1 and Figures 5.4 and 5.5). Because of its higher
specificity, the sandwich ELISA has been applied successfully to other studies for
detection of staphylococcal toxins in tissues from SIDS infants [Zorgani et al., 1997],
5.4.3 Induction of cross-reactive antibodies by DPT immunisation.
Reports from the early 1980's suggested that immunisation for DPT might be
associated with SIDS [Baraff et al., 1983]; however, extensive epidemiological
investigations found that immunisation reduced the risk of SIDS [Walker et al.,
1987; Hofmann et al., 1987], The second objective of this study was to investigate
how DPT immunisation could reduce the risk of SIDS.
As B. pertussis is not commonly isolated from infants and there are no reports of it
being found in SIDS cases [Mackenzie et al., 1996], it is possible that induction of
antibodies cross-reactive with the staphylococcal toxins is the cause of the observed
protective effect of DPT immunisation. In this study, the rabbit polyclonal anti-DPT
was far more reactive with TSST-1 than with any of the other staphylococcal
enterotoxins. Anti-TSST-1 was the only one of the antisera to the enterotoxins which
appeared to bind as well to PT as to its homologous antigen (Table 5.1) indicating
the presence of several shared epitopes on these toxins. The antiserum to SEC!
demonstrated the highest levels of binding to whole cell B. pertussis. The vaccine
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appears to have epitopes cross-reactive with the two staphylococcal enterotoxins
most commonly isolated from SIDS cases [Malam et al., 1992; Newbould et al.,
1989], Antibodies to the staphylococcal toxins might be induced by cross-reactive
epitopes on the pertussis, tetanus or diphtheria toxoids. Alternatively, they might be
induced by non-specific stimulation of B cells by the endotoxin in the whole B.
pertussis. Experiments in which individual toxoids, acellular pertussis vaccine and
cells of B. pertussis are used as individual immunogens are needed to answer these
questions.
5.4.4 Neutralisation of staphylococcal toxin bioactivity by antisera to
TSST-1 and the DPT vaccine.
Neutralisation of SEA and SEB but not SEC! by the antisera to TSST-1 (Figure 5.5)
supports the results of the direct ELISA (Table 5.1). The evidence gained from the
neutralisation assays showed that the polyclonal anti-DPT partially neutralises the
ability of all of the pyrogenic staphylococcal enterotoxins tested to elicit nitric oxide
production from monocytes, this was not observed with samples treated with normal
rabbit serum (Figure 5.4).
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5.4.5 Age distribution of SIDS cases following changes in the DPT
immunisation schedule.
Although the decline in SIDS has been attributed to the campaign to discourage the
prone sleeping position, the decrease in SIDS in Scotland began before the "back to
sleep" campaign was initiated in England and Wales in the autumn of 1991 [Gibson
et al., 1991]. The major change in infant care practices in all areas of Britain
occurred in October 1990, initiation of immunisation for DPT at the age of 2 months
instead of 3. This preceded the back to sleep campaign by a year. There have also
been increases in the proportion of infants immunized for pertussis and a decrease in
attendance at infant welfare clinics which acted as major opportunities for cross
infection [Southall et al., 1993].
There has been a decrease in the total number of SIDS cases in Southeast Scotland;
but, the proportion of SIDS cases aged less than or equal to 2 months has
significantly increased from 11% in 1988 to 56% in 1994 (x2 = 14.37, P<0.001).
These results indicate that the older age group is now better protected against SIDS.
The contributions of immunisation and the back to sleep campaigns need to be
assessed in detail in relation to reduction in SIDS cases.
The earlier immunisation of infants may prevent a small number of deaths by
asymptomatic pertussis suggested by epidemiological studies [Nicoll and Gardner,
157
1988; Lindgren et al., 1997]; however, as there are no reports of isolation of B.
pertussis from SIDS infants or identification of pertussis toxin in their tissues, it is
possible that the protective effect of DPT vaccination on SIDS is due to induction of
antibodies which are capable of partially neutralising the effects of the pyrogenic
staphylococcal toxins which have been identified in tissues of SIDS victims.
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CHAPTER 6
Synergy between bacterial toxins in
induction of inflammatory response from
human monocytes
6.1 Introduction
If a single micro-organism were responsible for sudden infant death syndrome, there
should be temporal or geographical clusters of these infant deaths associated with
outbreaks of the disease due to the organism in the community [Golding et al., 1985],
Except for an association between the presence of respiratory syncytial virus
infection among pre-school children [Williams et al., 1984] and studies in Norway in
which there is an association with pertussis infection in the community [Lindgren et
al., 1997], there is no strong epidemiological evidence for the involvement of a
single infectious agent in SIDS.
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The work of Oppenheim et al. [1994] has implicated Gram-negative bacteria by
demonstrating raised levels of IgM to endotoxin core in SIDS infants, particularly in
infants under 3 months of age. Studies in which the chick embryo model was used to
examine the effect of bacterial toxins on viability indicated that there might be
synergistic effects between products of S. aureus and E. coli [Drucker et al., 1992;
Sayers et al., 1995a], In a rabbit model the pyrogenic toxins of staphylococci have
been observed to enhance the effect of endotoxin by 100,000 fold [Bohach et al.,
1990], Both staphylococci and H. influenzae are often isolated from SIDS infants
[Telford et al., 1989] and also from healthy infants and their mothers in studies of
factors influencing bacterial carriage [Mackenzie et al., 1996], It has been observed
that strains of S. aureus which colonise humans commonly produce two or more
toxins, particularly TSST-1 and SEC] [Bohach et al., 1990],
Evidence from animal models indicates that TNF-a and nitric oxide are involved in
killing of virus infected mice by sub-lethal concentrations of staphylococcal
enterotoxin B and that a substantial degree of protection is afforded by treatment
with either dimeric soluble recombinant human TNF receptor-Fc fusion protein or
the nitric oxide synthase inhibitor aminoguanidine. This protective effect was not
observed with concomitant injection of anti-recombinant human interferon-y
[Sarawar et al., 1994],
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It has been suggested that some cases of SIDS might be due to induction of nitric
oxide or TNF-a from host cells by pyrogenic toxins or the effect of these toxins
being enhanced by other pathogenic substances including viruses, cigarette smoke
and small amounts of endotoxin [Blackwell et al., 1992; Blackwell et a/., 1995],
The objectives of this part of the project were:
1. To assess production of nitric oxide and TNF-a from human monocytes following
exposure to pyrogenic toxins or LPS;
2. To assess the effects of combinations of these toxins in order to test the
hypothesis that there are additive or synergistic effects between the toxins similar
to those observed with the chick embryo and mouse models.
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6.2 Materials and Methods
6.2.1 Monocyte purification.
Human peripheral blood monocytes were purified from buffy coats as described in
section 2.3.2.
6.2.2 Monocyte challenge assay.
Monocyte suspensions (0.5 ml) were added to the wells of a 24 well tissue culture
plate and incubated at 37°C for 15 min. The staphylococcal enterotoxins SEA, SEB,
SEC] and TSST-1 or lipopolysaccharide (LPS) from E. coli serotype 026:B6 were
diluted in DMEM without additives to give a final dilution at the optimum
concentration for each toxin assessed by dose response (Tables 4.3 And 6.4). The
monocytes were challenged with either 0.5 ml volumes of single staphylococcal
toxins (1 pg ml"1), 0.25 ml volumes of paired staphylococcal toxins (2 pg ml"1) or
0.25 ml volumes of staphylococcal toxins (2 pg ml"1) plus 0.25 ml volumes of LPS
(0.4 pg ml"1) (2.4.1). The cells were incubated at 37°C in 5% C02 and sampled at
various intervals. The culture supernatants were removed and centrifuged at 1,250 x
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g for 10 min to remove any remaining cells prior to determination of nitrite and TNF-
a content.
The time course experiment using SEB (4.2.7) was repeated with sampling of the
culture supernatants at 16, 20, 24 and 40 h for detection ofTNF-a.
6.2.3 Detection of inflammatory mediators.
Nitric oxide production in response to the toxins was measured by the nitrite assay
(2.5.1) and TNF-a by the bioassay with L-929 cells (2.6).
6.3 Results
6.3.1 The effect of endotoxin concentration on nitric oxide production.
Preliminary dose response experiments, similar to those for the staphylococcal
toxins, were carried out to ascertain the optimum LPS concentration for induction of
nitric oxide from human monocytes (Table 4.3). All of the staphylococcal toxins
showed the greatest stimulation of nitric oxide production at a concentration of 0.5
pg ml"1 The optimum concentration of LPS was found to be 0.1 pg ml"1 (Table 6.1).
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6.3.2 Induction of nitric oxide production by combinations of toxins.
When incubated with the staphylococcal enterotoxins and LPS, the levels of nitric
oxide production were greater than that of monocytes challenged with the
enterotoxins alone (Table 6.2). The effect of the staphylococcal toxin alone was
taken as 100% and the effect of addition of LPS (0.1 pg ml"1) expressed as a
percentage of the results with the staphylococcal toxin. The greatest increases were
seen in the response of monocytes challenged with SEB and SECp an increase of
146.5% and 85.2% respectively. These results show synergy between SEB and LPS,
and to a lesser extent between SECj and LPS. A slight (>30%) additive effect was
observed between SEA and TSST-1 and LPS. All of these increases were significant
according to the standard deviations.
The staphylococcal enterotoxins were also observed to provoke a greater production
of nitric oxide when present in combination with other staphylococcal enterotoxins
(Table 6.3). TSST-1 appeared to significantly enhance the effects of all of the other
toxins based on the standard deviations. This effect was most pronounced with SEB,
causing an increase in nitric oxide production of 58.6% over that of SEB alone.
Significant enhancement of activity was also observed with combinations of SEA
and SECi.
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6.3.3 The effect of time on TNF-oc production.
Initial time course experiments were carried out with SEB. The time course for
production of TNF-a was considerably shorter than that for nitric oxide with the
highest levels seen after 20 h. The results in Table 6.4 are expressed as the
percentage cytotoxicity of the culture supernatants for L-929 cells compared with
unchallenged cells. Figure 6.1 shows the TNF-a standard curve produced using a
range of dilutions of natural human TNF-a. Below 1 IU ml"1 there was little
cytotoxic effect on L-929 cells. The significant decrease in active TNF-a levels
observed across the concentration range, with the exception of 5 and 1 pg ml"1, from
20 to 24 hours may be due to release into the medium of soluble TNF-a receptors
rendering the molecule biologically inactive or the negative feedback effect of
interleukin-6 (IL-6) on TNF-a production [Aderka et al., 1989],
165





1.0 pg ml"1 0.139 0.0114
0.5 pg ml"1 0.182 0.0272
0.1 pg ml"1 0.247 0.0114
0.05 pg ml"1 0.200 0.0172
0.01 pg ml"1 0.129 0.0257
Table 6.2 NO production by monocytes challenged with enterotoxins and
enterotoxins plus LPS. (Data are mean of 6 expts.)
Toxin Control % Toxin + LPS % S.D.
SEA 100 128.0 (126.5-130.0) 1.4800
SEB 100 246.5 (216.6-282.9) 21.0735
SECi 100 185.2 (154.4-215.8) 30.2812
TSST-1 100 116.7 (111.4-121.3) 4.1751
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Table 6.3 nM nitrite production by human monocytes in response to challenge with
staphylococcal enterotoxins and combinations of enterotoxins.
(S.D. in brackets Data are mean of 4 experiments).






















Table 6.4 TNF-a response to staphylococcal enterotoxin B challenge by monocytes
over a 40 hour time course. Data expressed as % killing of L929 cells
compared with controls to which no toxin was added. (S.D. in brackets.
Data are mean of 3 experiments).
16 hours 20 hours 24 hours 40 hours
SEB
10 pg ml"1 0.463 13.00 8.19 1.71
(0.4374) (2.0127) (2.1496) (1.7136)
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Figure 6.1 TNF-a standard curve at 20 h (mean and standard deviation of 4
experiments).
169
6.3.4 The effect of toxin concentration on TNF-a production.
The pattern of production of TNF-a from monocytes in relation to dose varied with
different staphylococcal toxins. The data in Table 6.5 represents the means of 3
experiments and is expressed as the percentage cytotoxicity for L-929 cells of
supernatant from monocytes treated with toxin compared with unchallenged
monocytes. SEA, SEB and SECi showed a decrease in induction of TNF-a with
increasing dose across the concentration range tested, only TSST-1 showed an
increase with dose. For SEB and SEC! the greatest cytotoxicity was observed at a
concentration of 0.5 |ug ml"1 as in the nitric oxide studies. For SEA the maximum
effect was observed at 1 pg ml"1; but for TSST-1 the percentage killing was greatest
at 5 pg ml"1. There were far greater variations in the raw data for TNF-a than in that
for nitric oxide production. The dose response to LPS (Table 6.6) was also less clear
than that obtained for nitric oxide with the maximum killing observed with 0.1 pg
ml"1. The highest levels of TNF-a production were seen in response to challenge with
TSST-1.
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Table 6.5 Effect of concentration of staphylococcal enterotoxins on induction of
TNF-a production. (Data expressed as average % cytotoxicity for L929
cells and IU ml"1 from the standard curve compared with control to which
no toxin was added. Data are mean of 3 experiments).
Mean %
Toxin cytotoxicity (range) S.D. IU ml"1
SEA
10 pg ml"1 21.3 (13.68-27.35) 5.6901 3.3
5 pg ml"1 24.97 (21.25-28.06) 2.8156 4.1
1 pg ml"1 50.67 (40.05-59.60) 8.0695 8.0
0.5 pg ml"1 36.97 (29.60-42.10) 5.3432 6.5
0.1 pg ml"1 34.99 (31.52-37.60) 2.5555 5.4
SEB
10 pg ml"1 11.95 (9.85-13.07) 1.4838 >1
5 pg ml"1 13.52 (10.26-19.25) 4.0645 >1
1 pg ml"1 17.07 (12.85-21.08) 3.3634 1.5
0.5 pg ml"1 36.42 (30.32-42.13) 4.8296 5.7
0.1 pg ml"1 29.89 (24.05-34.25) 4.2936 4.3
SEC,
10 pg ml"1 3.44 (1.25-3.97) 1.6158 >1
5 pg ml"1 9.83 (5.25-15.89) 4.4680 >1
1 dg ml"1 10.43 (7.28-13.80) 2.6666 >1
0.5 pg ml"1 38.24 (15.86-51.62) 15.9238 6.1
0.1 pg ml"1 39.08 (19.21-52.35) 14.3116 6.5
TSST-1
10 pg ml"1 74.39 (65.83-81.05) 6.3571 64.1
5 pg ml"1 78.52 (72.12-84.51) 5.0662 77.0
1 pg ml"1 68.78 (63.55-79.83) 7.1724 47.9
0.5 pg ml"1 57.04 (51.08-62.15) 4.5591 13.1
0.1 pg ml"1 57.72 (46.12-65.86) 8.4233 15.0
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6.3.5 Induction of TNF-a production by combinations of toxins.
Table 6.7 represents the results of 4 experiments. An increase in TNF-a levels was
observed in monocytes challenged with enterotoxins plus LPS compared with those
challenged with the enterotoxins alone (100%). Although the increases were not as
great as those observed for nitric oxide, there were significant increases observed
with SEB plus LPS (80.3%) and TSST-1 plus LPS (25.2%). Non significant increases
were observed for the other enterotoxins plus LPS.
In 4 experiments, production of TNF-a in response to SEB was significantly
increased when in combination with SEC] and TSST-1. Other combinations,
SEA\SEB, SEAYTSST-1, and SECi\TSST-l, showed a significant decrease in the
observed percentage of killing (Table 6.8).
172
Table 6.6 Effect of LPS concentration on induction of TNF-a production expressed
as average % cytotoxicity for L-929 cells above cell controls. (Data are
mean of 3 experiments).
Mean %
LPS cvtotoxicitv (ranee) S.D. IU ml"1
1.0 pg ml"1 25.83 (15.21-38.91) 6.9235 4.5
0.5 pg ml"1 32.17 (14.11-48.33) 12.3248 5.0
0.1 pg ml"1 33.91 (20.79-42.37) 7.2560 5.2
0.05 pg ml"1 15.85 (3.31-35.86) 10.9381 >1
0.01 pg ml"1 28.76 (12.54-42.59) 11.2517 4.8
Table 6.7 TNF-a production by monocytes challenged with enterotoxins and
enterotoxins plus LPS.
Toxin Control % Toxin + LPS % S.D.
SEA 100 104.6 10.1304
SEB 100 180.3 27.3415
SECj 100 101.7 19.2861
TSST-1 100 125.2 7.4375
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Table 6.8 TNF-a production by human monocytes challenged with staphylococcal
enterotoxins and combinations of enterotoxins expressed as %
cytotoxicity for L929 cells compared with controls to which no toxin was
added. (S.D. in brackets. Data are mean of 4 experiments).























The role of monocytes, especially nitric oxide production and the cytokine cascade
responses involving tumour necrosis factor-a (TNF-a), interleukin 1 (IL-1) and
interleukin 6 (IL-6), are of great importance in combating bacterial infections;
however, when not adequately controlled, these inflammatory responses can have
potentially fatal effects. Certain conditions may be present that result in an
uncontrolled cytokine response leading to the death of the infant.
This study provides evidence that the staphylococcal enterotoxins can induce nitric
oxide and TNF-a production from human peripheral monocytes and that they can act
with each other and with LPS to produce greater amounts of these inflammatory
mediators. These results are consistent with those of studies using the chick embryo
model of SIDS [Drucker et al., 1992; Sayers et al., 1995a; 1996] showing similar
patterns of synergy between the toxins and LPS; however, use of human peripheral
blood monocytes and examination of the inflammatory mediators which animal
models suggest are involved is more relevant to SIDS in humans. LPS from E. coli
was used in this study as epidemiological studies have shown lower levels of IgG and
higher levels of IgM to endotoxin core in SIDS infants aged below 3 months
[Oppenheim et al., 1994], This organism is more common in bottle fed infants
[Bettleheim, 1990] in the SIDS age range and low concentrations of LPS have
previously been shown to enhance the lethality of the staphylococcal toxins in animal
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models [Lee et al., 1987; Drucker et al., 1992], Sayers et al. [1995a] showed
simultaneous isolation of both staphylococci and enterobacteria from nasopharyngeal
swabs of SIDS infants at a ratio of 7:1 compared with healthy infants.
The mean quantities of TNF-a present in the culture supernatants were calculated as
their percentage cytotoxicity for L-929 cells. Figures for IU ml"1 were derived from
the standard curve of the experiments. Results for the percentage cytotoxicity were
included in the tables to demonstrate the individual variations in response.
Given that the combination of TSST-1 and SEB provoked such a large increase in
nitric oxide production over that of either toxin alone, it is fortunate that co-
production of these two toxins is mutually exclusive as SEB producers do not possess
the TSST-1 structural gene (tst) [Kreiswirth, et al., 1989], This does not, however,
rule out the possibility of two different strains of S. aureus being present, one
producing TSST-1 and the other producing SEB. The non-significant change in NO
production in response to SEA when present with SEB and the very slight rise when
present with TSST-1 are also worthy of note as studies on the competitive binding of
the staphylococcal toxins using murine fibroblasts have shown that SEA can
completely inhibit the binding of SEB [Fraser, 1989] and TSST-1 [Chintagumpala et
al., 1991], It is possible that bound SEA either covers residues on the MHC class II
molecule which are essential for SEB/TSST-1 binding or that its binding causes
conformational changes in the MHC molecule thus obscuring the SEB/TSST-1
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binding sites (Figure 6.2). SEB and TSST-1 have little effect on SEA binding, this
suggests the presence of multiple binding sites for SEA on MHC class II molecules.
Similar studies have shown that neither SEB or TSST-1 compete with the other toxin
for binding sites [Scholl et al., 1989; Chintagumpala et al., 1991] (Figure 6.2). The
increased nitric oxide production in response to the SEB/TSST-1 combination is
consistent with these findings.
These studies addressed the mechanisms by which combinations of staphylococcal
toxins and staphylococcal toxins with endotoxin could produce the results observed
in the chick embryo model. The next stage in the study was to assess the effects of
virus infection and exposure to cigarette smoke, since nicotine had been shown in the
chick embryo model to enhance the lethality of the bacterial toxins.
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MHC MHC
Figure 6.2 Competitive binding of the staphylococcal toxins SEA, SEB and
TSST-1: (a) Single toxins appear to bind to discrete sites on the MHC II
molecule, (b) When present in combination with SEA binding of SEB
and TSST-1 is completely inhibited.
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Chapter 7
The effects of cigarette smoke and viral
infection on inflammatory responses of
human monocytes
7.1 Introduction
The effect of maternal smoking has been identified as one of the major risk factors
associated with SIDS but its actual significance has proved difficult to judge in
epidemiological studies as it is linked with lower socioeconomic class [Stephenson
et al., 1997], Infants of lower income families are at a higher risk of SIDS for a
number of reasons other than the high percentage of mothers who smoke relative to
higher income families. The risk factors commonly associated with lower
socioeconomic class include poorer housing conditions, larger numbers of siblings,
shorter pregnancy interval, younger and unmarried mothers, lower levels of prenatal
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care and poorer nutrition. Many of these factors are also found among groups such as
native Americans [Gibson, 1995] and Australian Aborigines [Alessandri et al., 1996]
in which there are higher levels of bacterial carriage and infection [Todd et al., 1985;
Leach et al., 1994],
Evidence for the role of maternal smoking in relation to infection and SEDS can be
gained from studying cultures in which smoking is not linked with socioeconomic
class. In Greece approximately one third of the female population smoke irrespective
of class and educational level. Kremastinou et al. [1994] found that there was a
significant correlation between smoking by mothers and other household members
involved in child care and carriage of meningococci among Greek school children.
Smoking could lead to colonisation by potentially pathogenic bacteria by enhancing
the incidence of respiratory virus infection. Isolation of pathogenic bacteria such as
staphylococci [Musher and Fainstein, 1981] and meningococci [Blackwell el al.,
1992] is also higher from smokers themselves, thus providing a reservoir for
infection which could be transmitted to their children.
Another problem in determining the role that smoking plays in SIDS is that most of
the evidence comes from epidemiological studies in which the data is generally
collected retrospectively. This presents the problem of obtaining accurate
information on the extent of smoking in the household due to under reporting of the
number of cigarettes smoked per day and the fact that it is usually only maternal
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smoking habits that are investigated. The presence of other smokers in the immediate
or extended family can have a great effect on the amount of cigarette smoke to which
an infant is exposed.
Work by Sayers et al. [1995b] assessed the effect of nicotine on the lethality of
bacterial toxins isolated from SIDS infants in a chick embryo model. Their results
showed that even very low concentrations of nicotine could enhance the effects of
non-lethal toxin mixtures which resulted in killing of the chick embryos. Their study,
as with most experimental models of the effects of tobacco smoke, used purified
nicotine which although undoubtedly very toxic, is only one of the many compounds
present in tobacco smoke. Assessing the interactions of all of the components of
tobacco smoke to enhance or detract from the toxicity of nicotine would provide a
more accurate model.
Studies by Sarawar et al. [1994], using a mouse model, and Lundemose et al. [1993]
using human peripheral blood leukocytes indicated that virus infection is also
capable of enhancing the effects of endotoxin and the pyrogenic toxins. Both studies
found evidence of increased TNF-a production which, when blocked with a soluble
TNF-a receptor in the mouse model reduced the lethality of the virus/toxin
combination.
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The aim of this part of the study was to assess interactions between an infusion of the
soluble components of cigarette smoke, the staphylococcal toxin TSST-1 and
respiratory syncytial virus (RSV) on induction of TNF-a and nitric oxide,
inflammatory mediators implicated in the mouse model [Sarawar et al., 1994],
7.2 Materials and methods
7.2.1 Production of cigarette smoke extract (CSE).
A hand operated vacuum pump was used to draw cigarette smoke through DMEM
with no additives or serum. The apparatus consisted of a 250 ml Duran bottle with
two holes drilled in the cap. Through one of these holes was placed a length of
sterilised tubing with a connection to a piece of larger bore tubing which held the
cigarette. Another length of tubing was run from the other hole to the vacuum pump.
The cigarette smoke was drawn through the medium by the change in pressure
caused by extracting the air from the upper part of the bottle (Figure 7.1). The smoke
from 10 cigarettes (Regal King Size) was infused into 100 ml of the medium at a rate
of approximately 1 cigarette per 10 min to provide a stock solution of 0.1
cigarette/ml. The medium was filter sterilised using a 0.2 pm Millipore syringe filter







Figure 7.1 Apparatus used in the production of the cigarette smoke extract.
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7.2.2 Dose response to CSE.
The monocyte challenge assay (2.4.1) was used to determine the optimum
concentration of CSE for use in the study. Human peripheral blood monocytes were
purified from buffy coats as described previously (2.3.2), their viability assessed by
Trypan blue exclusion, and cultured at 2 x 106 cells ml"1 (0.5 ml) in 24 well tissue
culture plates at 37°C and 5% C02. Doubling dilutions of CSE (1/1 to 1/512) were
made in DMEM with no additives (0.5 ml) and added to the wells. The plates were
then incubated for 72 h at 37°C in a 5% C02 atmosphere. The culture supernatants
were removed and centrifuged at 1,250 x g to remove cellular debris and stored at
-20°C prior to determination of nitric oxide content. The optimum concentration of
TSST-1 had been determined previously (Table 4.3).
Dose response experiments were also carried out with IFN-y (Sigma) (25, 50, 100
and 200 IU ml"1), nicotine (Sigma) (50, 100, 200 and 400 pg ml"1) and the nicotine
metabolite cotinine (Sigma) (50, 100, 200 and 400 pg ml"1).
7.2.3 Preparation ofRSV infected monocytes.
The Edinburgh strain of the respiratory syncytial virus (RSV) (subgroup A) was
grown by Dr. M. Raza in 24 h sub-confluent monolayers of HEp-2 cells incubated
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with RSV at a multiplicity of infection (MOI) of 2 infectious particles per cell for 1
h. The monolayers were maintained in Eagle's minimum essential medium (Gibco)
(pH 7.4) containing NaHC03 (0.85 g l"1), L-glutamine (2 mM), penicillin (100 IU
ml"1), streptomycin (100 pg ml"1) and 10% FCS (v/v) for 48 h. The virus was
harvested by freezing at -70 °C and thawing to lyse the cells. The suspension was
centrifuged at 700 x g for 10 min to remove cellular debris, resuspended in DMEM
with additives plus 10% FCS (v/v) and adjusted to 2 x 106 plaque forming units ml"1.
Human monocytes obtained from buffy coats (2.3.2) were distributed into the wells
of a 24 well tissue culture plate as 1 x 106 cells per well in DMEM with additives
plus 10% FCS (v/v) (0.5 ml). DMEM with no additives (0.5 ml), RSV (MOI=2) (0.5
ml), or a combination of RSV (MOI=2) and cigarette smoke extract (0.5 ml) were
then added to the wells.
The proportion of monocytes infected with RSV in each sample was determined by
an indirect immunofluorescence technique using a monoclonal antibody to
glycoprotein G ofRSV (kindly supplied by Prof. P.J. Watt, Southampton University).
Monocyte suspensions (1 x 106 cells ml"1) (200 pi) were incubated with anti-
glycoprotein G (1/100) (100 pi) for 30 min at 37 °C. The cells were washed 3 times
in PBS by centrifugation at 680 x g for 7 min. and resuspended in PBS (200 pi).
FITC-conjugated anti-mouse IgG (1/200) (100 pi) was added to the suspensions and
the cells incubated at 37°C for 30 min prior to washing 3 times in PBS as above. The
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cells were resuspended in 200 pi of PBS and fixed with 100 pi of 1% buffered
paraformaldehyde. The proportion of fluorescent cells was determined by flow
cytometry.
7.2.4 Dose response of RSV infected and non-infected human
peripheral blood monocytes to CSE and TSST-1.
The monocyte challenge assay (2.4.1) was used to test the ability of CSE and TSST-1
to induce production of nitric oxide and tumour necrosis factor-a from normal
human monocytes and monocytes infected with RSV. Dilutions of CSE and TSST-1
were made in DMEM with no additives. The monocyte suspensions (1 x 106
cells/well) were cultured in 24 well tissue culture plates at 37°C in 5% C02. After
incubation for 24 h, TSST-1 (10 pi at 5 pg ml"1) and/or CSE ( 100 pi at 0.1 cigarette
ml"1) were added to the appropriate test wells by withdrawing 200 pi of the culture
supernatant and adding the TSST-1 and/or CSE prior to returning the supernatant to
the well. This procedure was carried out to avoid abrupt contact of concentrated
toxin with the cells and to ensure a uniform toxin concentration throughout the well.
Samples were collected from each well after a further 20 h for TNF-a detection and
72 h for nitric oxide detection, the optimum sampling times having already been
determined (Tables 4.3 and 6.4). Negative controls containing no monocytes
included DMEM plus CSE and/or RSV. The samples were centrifuged at 1,250 x g
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to remove cellular debris and stored at -20°C prior to determination of TNF-a and
NO content.
7.2.5 Determination of TNF-a content.
The TNF-a activity of the samples was estimated as described in section 2.6. The
results are expressed as the percentage cytotoxicity for L-929 cells.
7.2.6 Determination ofnitric oxide content.
Nitric oxide production was measured by the nitrite assay (2.5).
7.2.7 Statistical methods.
The data obtained from the test samples were compared with controls containing
only medium or other test groups using paired t tests.
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7.3 Results
7.3.1 Nitrite production in response to CSE.
Dose response experiments found CSE to contain significant levels of nitrites. To
discriminate between CSE nitrites and evidence of cellular NO production, a 1/10
dilution of CSE (0.01 cigarettes ml"1) was used in the subsequent experiments
(Figure 7.2).
7.3.2 Dose response to interferon-y, nicotine and cotinine.
In 2 experiments with 4 donors no dose response to IFN-y, nicotine or cotinine was
observed in the concentration levels tested (Table 7.1). Concentrations of IFN-y 50
IU ml"1, nicotine and cotinine 0.1 pg ml"1 were used in the subsequent experiments.
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DILUTION
Figure 7.2 Dose response to dilutions of cigarette infusion measured by nitric oxide
production from human peripheral blood monocytes. Starting
concentration (1\1) is equal to 0.1 cigarettes per ml ofmedium (mean of
2 experiments with 2 donors).
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Table 7.1 Dose response ofmonocytes to interferon-y, nicotine and cotinine by
nitric oxide and TNF-a production (mean of 2 experiments).
% cytotoxicity
Sample nM nitrite for L-929 cells
Monocyte Control 0.0000 53
IFN- y 200 IU 0.0429 60
100 IU 0.0143 24
50 IU 0.0429 60
25 IU 0.0000 56
NICOTINE 0.4 pg ml"1 0.0429 47
0.2 pg ml"1 0.0000 47
0.1 pg ml"1 0.0000 36
0.05 pg ml"1 0.0000 35
COTININE 0.4 pg ml"1 0.0858 54
0.2 pg ml"1 0.0429 56
0.1 pgml"1 0.0715 44
0.05 pg ml"1 0.0715 41
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7.3.3 The effect of IFN-y, nicotine and cotinine on release of TNF-a
and nitric oxide from human monocytes.
The effects of IFN-y, nicotine and cotinine were assessed with cells from 6 donors.
There was no significant increase in the percentage killing of L-929 cells by medium
from cells exposed to nicotine (mean 34%, SE 8.7) or cotinine (mean 39%, SE 7.2)
compared with cells incubated with DMEM alone (mean 32%, SE 7.2). Incubation
with IFN-y did, however, result in a significant increase in TNF-a levels (mean 51%,
SE 3.0, CI 6.2, 19.0, P=0.012) (Figure 7.3)
Production of NO was not significantly increased compared with control levels (0.1
nM ml"1, SE 0.03) in the presence of IFN-y (mean 0.15 nM ml"1, SE 0.03) or nicotine
(mean 0.13 nM ml"1, SE 0.03) but was significantly increased by the presence of
cotinine (mean 0.26 nM ml"1, SE 0.03, 95% CI 0.03, 0.15, P=0.018) (Figure 7.4).
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Figure 7.3 TNF-a activity elicited from human monocytes in response to IFN-y,










Figure 7.4 Release of nitric oxide from monocytes in response to IFN-y, nicotine or
cotinine.
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7.3.4 The effect ofCSE, RSV and/or TSST-1 on TNF-a release from
human monocytes.
The TNF-a activity observed in experiments with monocytes from 31 donors is
expressed as cytotoxicity for L-929 cells (Figure 7.5). In experiments with monocytes
from 24 donors, compared with supernatants from cells incubated with medium
alone (mean 45%, SE 4.5), supernatants from cells incubated with CSE had
significantly increased levels of TNF-a (mean 60%, SE 5.3, 95%CI 3.8, 19.7, P =
0.006), as did the supernatants from RSV infected cells (mean 68%, SE 4.5, 95%CI
16.4, 34.1, P = <0.001). In experiments with monocytes from 31 donors, compared
with supernatants from cells incubated with medium alone (mean 48%, SE 4.5),
supernatants of cells incubated with TSST-1 had significantly increased levels of
TNF-a activity (mean 63%, SE 4.3, 95%CI 6.2, 24.3, P = 0.002).
The effects of combinations of TSST-1 with CSE, RSV or both on of TNF-a activity
were examined in experiments with cells from 20 donors. Compared with TNF-a
activity detected in supernatants from cells exposed to medium alone (mean 41%, SE
5.5), a non-significant increase was observed in supernatants from cells incubated
with CSE and TSST-1 (mean 51%, SE 7.1). Compared with controls, a significant
increase was observed in supernatants from cells incubated with RSV and TSST-1
(mean 76%, SE 3.5, 95%CI 25.7, 42.4, P = <0.001) and in supernatants incubated
with RSV, CSE and TSST-1 (mean 71%, SE 6, 95%CI 19.9, 44.9, P = <0.001).
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Compared with TNF-a activity in supernatants from cells exposed to CSE alone
(mean 61%, SE 7.2), there was decreased activity in supernatants of cells incubated
with a combination of CSE and TSST-1 (mean 51%, SE 7.4, NS), but the levels
observed for combination of CSE, RSV and TSST-1 were significantly higher (mean
71%, SE 6.5, 95%CI 11.7, 40.0, P = 0.002). Compared with TNF-a activity in
supernatants from cells incubated with RSV alone (mean 68%, SE 5.6), supernatants
from cells incubated with RSV and TSST-1 had increased levels of activity (mean
76%, SE 3.6, 95%CI 3.1,14.3, P = 0.001), as did the supernatants from cells
incubated with all three agents (mean 71%, SE 6.5) but the difference was not
significant.
The mean paired increases in percentage of killing of L-929 cells due to various
combinations of agents compared with controls is summarised in Figures 7.6a, b, and
c. CSE increased the TNF-a response from RSV infected cells (P = 0.001),
decreased the response from cells exposed to TSST-1 (non-significant) and did not
affect RSV-infected cells incubated with TSST-1. TSST-1 decreased TNF-a
response from cells incubated with CSE (non-significant) but stimulated the activity
when cells were infected with RSV (P = 0.001). TSST-1 had no effect on TNF-a
response from RSV infected cells incubated with CSE. RSV increased TNF-a
production from cells incubated with CSE, TSST-1 or both (P = 0.003, 0.003 and
0.03 respectively).
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7.3.5 The effect of CSE, RSV infection and/or TSST-1 on NO release
from human monocytes.
The supernatants from cells of 31 donors were examined for nitrite levels induced in
response to CSE, RSV or TSST-1 (Figure7.7). Compared with supernatants from
cells incubated with medium only (mean 0.36 nM ml"1, SE 0.05), supernatants from
cells incubated with CSE had lower levels of NO (mean 0.33 nM ml"1, SE 0.05,
95%CI -0.16,-0.03, P = 0.009). RSV infection did not significantly affect the levels
of NO detected (mean 0.34 nM ml"1, SE 0.57). Supernatants from cells incubated
with TSST-1 alone or combinations of agents including TSST-1 had levels of nitrite










Figure 7.5 TNF-a activity elicited from human monocytes in response to

































Figure 7.6 (a, b, and c) Paired differences in production ofTNF-a in response to











Figure 7.7 Production of nitric oxide by human monocytes in response to
combinations ofRSV, CSE, and TSST-1.
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7.3.6 Variability ofTNF-a and NO responses of individual donors.
Each set of experiments was carried out with cells from different donors. Individual
TNF-a and NO responses to CSE, RSV infection and TSST-1 separately and in
combination, are summarised in Table 7.2. TNF-a and NO responses of the test
samples were classified as very high if the levels of killing of L-929 cells or levels of
nitrite were more than twice the value of the controls in which monocytes were
cultured with medium alone. Responses were classified as very low if the levels of
the test samples were less than half those of the control. The most common pattern
observed in the experiments was increased TNF-a production and decreased NO
production.
Compared with the controls, exposure to CSE increased TNF-a activity in 75% of
experiments and NO levels in 33%. The remainder showed varying degrees of
inhibition in comparison to the control. Very high levels of TNF-a activity were
observed in 12% of experiments but none showed very high levels ofNO production
in response to CSE. Very low levels ofTNF-a in response to CSE were not observed,
but in 12% of experiments, the NO response of the test was less than half that of the
control. In response to CSE, cells from 25% of the donors showed increases in both
TNF-a activity and release of NO and 25% showed a decrease in both. Increased
levels of TNF-a activity and decreased NO levels were observed in 42% of
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experiments. Among these, monocytes from 4% of donors showed extreme responses
(Table 7.2).
RSV infection resulted in increased TNF-a activity in 92% of experiments and
increased NO release in 50%. Compared with uninfected controls, RSV infection
resulted in very high levels of TNF-a activity in 25% of experiments and very high
levels of NO in 25 %. Compared with uninfected controls, RSV infection resulted in
very low levels of TNF-a activity in 4% of experiments and of NO in 21%. Both
TNF-a and NO responses were increased in 50% of experiments and decreased in
8%. RSV infected monocytes exhibited increased TNF-a activity and reduced
production ofNO in 33% of experiments; 4% showed extreme responses.
Exposure to TSST-1 increased TNF-a activity in 81% of experiments and NO
production in 58%. Compared with the controls, very high TNF-a activity was
observed in 26% of experiments and NO in 6% of experiments. Compared with the
controls, TSST-1 resulted in very low levels of TNF-a activity in 3% of experiments
and ofNO in 12%. Both TNF-a activity and levels of NO were increased in 52% of
experiments and decreased in 13%. TNF-a activity was increased and NO decreased
in 29% of experiments. None showed extreme responses.
The effects of CSE and RSV were assessed with monocytes from 15 donors. RSV
and CSE resulted in increased levels of TNF-a activity in 87% of experiments and
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increased NO in 13%. Compared with controls, exposure to RSV and CSE induced
very high TNF-a activity in 48% of experiments and very high levels ofNO in 7%.
Compared with controls, very low levels of TNF-a activity and NO were observed in
7% and 48% of experiments respectively. Levels of both TNF-a activity and NO
were increased from control levels in 13% of experiments and decreased in 13%.
RSV infected monocytes challenged with CSE exhibited increased TNF-a activity
and decreased NO production in 67% of experiments with 20% showing extreme
responses.
The effects of CSE and TSST-1 were assessed with monocytes from 20 donors.
Compared with the controls, exposure to CSE and TSST-1 increased TNF-a activity
in 65% of experiments and NO levels in 45%.Very high levels of TNF-a activity
were observed in 30% of experiments but none showed very high levels of NO
production in response to CSE and TSST-1. Very low levels of TNF-a activity in
response to these agents were observed in 5% of experiments and of NO in 20% of
experiments. In response to CSE and TSST-1, cells from 25% of the donors showed
increased TNF-a activity and NO production and 15% showed a decrease in both.
Increased levels ofTNF-a activity and decreased NO levels were observed in 40% of
experiments. No extreme responses were observed.
The effects ofRSV and TSST-1 were assessed with monocytes from 20 donors. RSV
and TSST-1 resulted in increased levels of TNF-a activity in 95% of experiments
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and increased NO release in 30%. Compared with controls, RSV and TSST-1
resulted in very high levels of TNF-a activity in 40% of experiments and very high
levels ofNO in 20 %. Compared with controls, very low levels of TNF-a activity in
response to RSV and TSST-1 were not observed, but in 30% of experiments the
levels of NO were classified as very low. Both TNF-a and NO responses were
increased in 30% of experiments and decreased in 5%. RSV infected monocytes
challenged with TSST-1 exhibited increased TNF-a activity and reduced production
ofNO in 50% of experiments. Again no extreme responses were observed.
Exposure to CSE, RSV and TSST-1 increased TNF-a activity in 95% of experiments
and NO production in 35%. Compared with the controls, very high levels of TNF-a
activity were observed in 60% of experiments and of NO in 5% of experiments in
response to the three agents. Compared with the controls, these agents resulted in
very low levels of TNF-a activity in 5% of experiments and of NO in 25%. Both
TNF-a activity and NO production was increased in 35% of experiments and
decreased in 6%. TNF-a activity was increased and NO production decreased in 55%
of experiments; 20% showed extreme responses.
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Table 7.2 Response of individual donors to challenge with combinations ofRSV,
CSE, and TSST-1 by production of TNF-a and nitric oxide.
% donors
Challenge Increased Decreased Very Very t TNF-a
High Low I NO
(extreme)
CSE TNF-a 75 25 12 0 42 (4)
(n=24) NO 33 63 0 12
TNF-a+ NO 25 25 0 0
RSV TNF-a 92 8 25 4 33 (4)
(n=24) NO 50 46 25 21
TNF-a+ NO 50 8 0 4
TSST TNF-a 81 19 26 3 29 (0)
(n=31) NO 58 42 6 12
TNF-a+ NO 52 13 0 0
CSE+RSV TNF-a 87 13 48 7 67(20)
(n=15) NO 13 87 7 48
TNF-a+NO 13 13 0 0
CSE+TSST TNF-a 65 35 30 5 40 (0)
(n=20) NO 45 50 0 20
TNF-a+ NO 25 15 0 0
RSV+TSST TNF-a 95 5 40 0 50 (0)
(n=20) NO 30 60 20 30
TNF-a+ NO 30 5 0 0
RSV+CSE+ TNF-a 95 5 60 5 55(20)
TSST NO 35 60 5 25
(n=20) TNF-a+ NO 35 6 0 0
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7.4 Discussion.
While there is evidence that viral infection and cigarette smoke might enhance
bacterial colonisation of infants [Saadi et al., 1996; Musher and Fainstein, 1981], the
effects of these agents in relation to TSST-1 on induction of inflammatory mediators
had not been examined. Evidence that sub-lethal amounts of SEB can kill virus
infected mice has been shown by Sarawar et al. [1994] implicating the production
and interaction of the inflammatory mediators TNF-a and IFN-y. The study by Sayers
et al. [1995b] with toxins produced by bacteria isolated from SIDS cases showed an
increased lethality of tolerable quantities of S. aureus and Klebsiella pneumoniae
toxins when the toxins were present in combination (9% killing at a dilution of 1/8)
which was increased by the addition of nicotine (800 ng ml"1 neat solution) (82%
killing at 1/8 to 46% killing at 1/32). Combinations of toxins from S. aureus and E.
coli showed an even greater response to nicotine (toxin combination = 9% killing at
1/4, toxin combination + nicotine = 82% killing at 1/4 to 73% killing at 1/32). On the
basis of such evidence the activities of cigarette smoke and viral infection were
assessed for their effect on the ability of TSST-1 to induce inflammatory mediators
from human monocytes.
Individual variations observed in the inflammatory response to toxic stimuli and
RSV infection, though controlled for using unchallenged monocytes, could reflect
stimulation of the cells prior to collection from the donors. As the buffy coats
206
obtained from the SNBTS were from anonymous donors there was no way to
ascertain if the donors were suffering from infection. As a safeguard against the use
of stimulated monocytes from unwell blood donors, buffy coats containing unusually
high numbers of monocytes (>4 x 107 monocytes per 50 ml buffy coat) were
routinely discarded. The level of production of inflammatory mediators has been
observed to vary with blood group, cells from donors of blood group O produced
significantly greater quantities of TNF-a, IL-6 and nitric oxide than those from
donors of blood group A in response to H. pylori antigens [Alkout, 1997], for this
reason all of the buffy coat samples used throughout this work were from O rhesus
positive donors. Research into a potential role for blood group as a risk factor in
SIDS appears to be limited to studies on maternal blood group, with one study
identifying type O and two studies identifying type B as being associated with an
increased incidence of SIDS [reviewed by Kelly and Shannon, 1982],
The increased production of TNF-a by virus infected monocytes in response to
TSST-1 and/or CSE was not generally accompanied by an increase in NO
production. For the majority of experiments, production of NO was decreased. The
production of NO by macrophages and alveolar lining cells in the airways is known
to have a protective effect by counteracting bronchoconstriction induced by
inflammatory mediators such as leukotriene D4 (LTD4) [Hogman et al., 1993], It
would appear that the combinations of toxin, virus and CSE used in this study are
capable of reducing this protective mechanism.
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The evidence for an additive, if not synergistic, effect between RSV, CSE and TSST-
1 supports the hypothesis that the interactions of infectious and environmental agents
on production of inflammatory mediators could contribute to the death of a
susceptible infant. These findings with partially purified toxins and human cells are
consistent with those of Sayers et al. [1995b] with the chick embryo model. The
toxin extraction method of Sayers et al. [1995a,b] employed isolates of bacteria from
SIDS cases cultured overnight on a dialysis membrane over agar, the bacterial
growth was harvested in Hank's balanced salt solution which was then centrifuged
and filter sterilised for use as the toxin preparation. The toxicity of these crude
preparations relative to the commercially available purified toxins, might have more
powerful effects such as those observed with nicotine and cotinine compared with
the water soluble smoke extract. The crude toxin extracts could contain substances
such as peptidoglycan and lipoteichoic acid which are capable of acting
synergistically to elicit powerful inflammatory responses [De Kimpe et al., 1995],
Further work is also required to clarify the mechanisms underlying the effect of
tobacco smoke on the responses of monocytes to bacterial toxins. Development of a
more extensive cytokine profile from in vitro studies would provide guidance as to
which cytokines should be sought in SIDS victims.
Although S. aureus is present in over 50% of infants in the 0 to 3 month age range,
production of the pyrogenic toxins is probably induced only on rare occasions. The
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toxins are produced only at temperatures between 37 and 40°C [Bohach et al., 1990]
which is higher than the normal temperature of the nasopharynx (approximately
35.6°C) [Molony et al., 1996], Many SIDS victims have a mild respiratory infection
in the week prior to their deaths. This could result in fever and blockage of the nasal
passage which could increase the temperature of the nasopharyngeal mucosa to the
permissive temperature for toxin induction. Recent studies in young children indicate
that the prone position results in significantly higher temperatures in the nose, some
of which reached 37°C [Molony et al., submitted for publication].
The resulting local toxin concentration would stimulate immune cells to produce the
cytokines TNF-a and IL-1 which would sustain the elevated temperature allowing
further toxin production. The prolonged toxin-cytokine production would form a
positive feedback loop resulting in a systemic TNF-a response. Studies in both
human and animal models have shown that elevated TNF-a levels produce effects
commonly associated with severe toxaemia [Parrillo, 1993].
Further evidence for the role of TNF-a in SIDS comes from a study by Ikejima et al.
[1988] on the induction of shock-like states in rabbits by administration of TNF-a
and IL-1. Their findings showed a synergistic effect between TNF-a and IL-1 with
the major target organ being the lungs. This shock state resulted in an accumulation
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of proteinaceous fluid and immune cells in the alveolar spaces and petechiae, both
common findings in SIDS victims at autopsy [Howat et al. 1994].
A possible link between the night time prevalence of SIDS cases and control of the
inflammatory response by Cortisol [Reichlin, 1993] and other glucocorticoids has
been suggested [Blackwell et al., 1995], As the adrenal gland decreases in weight in
the first two months of life, there is a concomitant decrease in plasma Cortisol levels
[Wittekind et al., 1993], In adults, circadian variations in Cortisol production have
been reported, secretion rates drop in the early hours of the morning when the
majority of SIDS cases are thought to occur. In adults, the ability to control TNF
responses to endotoxin are significantly reduced after midnight [Pollmacher et al.,
1996], During the infant's development, Cortisol levels drop dramatically in the week
following the switch to "adult-like" body temperature rhythms. This period following
this switch could be when infants are more susceptible to the pathological effects of
these inflammatory mediators. If the infection and toxin challenge were to occur
outwith this time period, either while levels ofmaternal transplacental antibodies are
high or afterwards when the infants own immune system has started to produce




Detailed discussion of results is given at the end of each chapter. The purpose of this
chapter is to give an overview of the project findings, to assess the implications of
the work for further reducing the incidence of SIDS, to examine ways in which
experimental techniques could be improved and to propose further work to clarify
the findings of the study.
The general aim of this study was to examine how common bacteria might play a
role in sudden infant death syndrome. It has long been recognised that a certain
number of SIDS deaths might be due to bacterial colonisation; however, very few of
the studies attempting to test this hypothesis have postulated how such bacteria could
cause the death of an infant in a way which would be consistent with the
epidemiological and post-mortem findings commonly associated with SIDS. Given
the highly probable multi-factorial nature of a problem as complex as SIDS, it is
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unlikely that any one hypothesis will ever explain the cause ofmore than a subset of
the deaths attributed to it. The remit of this project was to examine the way in which
the toxins of common bacteria could trigger a series of events leading to a SIDS
death in the context of developmental and environmental factors identified in
epidemiological studies.
The Lewis3 blood group antigen acts as a receptor on epithelial cells for certain
bacterial species, including S. aureus. The increased proportion of infants expressing
this antigen during the age range in which the majority of SIDS cases occur could
contribute to density of colonisation by toxigenic bacteria such as S. aureus or some
Gram-negative bacteria often isolated from SIDS infants such as H. influenzae
(Chapter 3). Colonisation would not be sufficient to cause the death of an infant as S.
aureus only produces toxins at temperatures of 37 to 40°C and normal local
temperature is lower than this. Some other factors must raise the temperature of the
nasopharyngeal mucosa to this level. This effect could be achieved by enviromnental
causes such as overwrapping, an excessively warm room, placing the infant in the
prone position, or by a concomitant infectious agent such as a minor respiratory tract
infection (commonly observed in SIDS infants in the week prior to death). Once
toxin production has begun, this elevated temperature will be maintained by the
pyrogenic effect of the toxins themselves and also by the effects of the
proinflammatory cytokines produced by the infant in response to the toxins. At this
stage decreased night-time levels ofCortisol associated with developmental changes
212
could result in a period when an infant is more vulnerable to the detrimental effects
of inflammatory mediators. Toxin production and an uncontrolled systemic cytokine
response might lead to "pre-morbid toxic shock" and death. For the effect to occur,
the toxins would have to be present in very high concentrations, or acting in synergy
with small amounts of endotoxin, viral induced cytotoxins or toxic substances such
as cigarette smoke in the environment. The prone sleeping position could enhance
density of colonisation by toxigenic bacteria; however, if the toxins were to act
synergistically, death could possibly result from a sparse colonisation or from
infection with bacterial strains which produce only minor amounts of toxins such as
S. epidermidis which would not be seen as being sufficiently significant to cause
death.
Epidemiological studies, as well as identifying factors which increase the risk of
SIDS, have identified certain factors which appear to decrease its likelihood. One
such factor is immunisation against DPT. This apparent protective effect was
observed in southeast Scotland when the infant immunisation schedule for DPT was
changed from 3 to 2 months of age. There was a downward shift in the age
distribution of SIDS cases. This effect was studied in relation to the hypothesis that
antibodies produced by the infant in response to the DPT vaccine could bind to
shared epitopes on the staphylococcal toxins resulting in partial protection from these
toxins. Since B. pertussis has not been isolated from SIDS victims and isolation of S.
aureus parallels the age distribution of SIDS, the effect of DPT immunisation is
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more likely to be induction of antibodies cross-reactive with the staphylococcal
toxins.
8.1 Detection ofmicrobial surface antigens that bind Lewis3.
The first stage of the project was to determine which bacteria were capable of using
the Lewis3 antigen as a receptor. At the time of this study synthetic oligosaccharides
of the Lewis antigens were not commercially available and affinity purified Lewis
antigens from donor samples are usually bound to lipids and proteins. The problem
was addressed by the production of an anti-idiotypic antibody to anti-Lewis3, the Fab
portion of which would have the same spatial configuration as the Lewis3 antigen.
This method provided a sufficiently high yield of anti-idiotypic antibody to screen
large numbers of bacterial isolates for their ability to bind to Lewis3. The anti-
idiotypic antibody was left attached to the protein A Sepharose beads used in the
final stage of purification to avoid excessive dilution of the antibody and to enhance
the clarity of reactions in the bacterial agglutination assay. This provided a rapid and
reproducible agglutination assay which was easy to read by eye, and the controls
included with each test ensured that no false positives were recorded due to bacteria
binding to the protein A Sepharose beads or autoagglutination. As synthetic blood
group oligosaccharides are now available at reasonable costs the value of this assay
as a screening tool is somewhat reduced, however; it was useful in the context of this
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study to determine which bacteria would be expected to play a role in SIDS during
the age range when infants are at greatest risk.
8.2 Lewis antigen expression on human monocytes and binding of
pyrogenic toxins.
The majority of work on superantigens has concentrated on their interactions with
MHC class II molecules; however, as it has been shown that the pertussis toxin of B.
pertussis can utilise the Lewis3 antigen as a receptor [van t'Wout et al., 1992], the
ability of the staphylococcal toxins to bind to this antigen was examined. Although
all four of the staphylococcal toxins tested bound to the surface of human monocytes,
binding of SEA and SEB could not be reduced by pre-treatment with antibodies to
Lewis3 or Lewisb indicating that they are binding to other cell surface antigens. The
toxins for which binding was significantly reduced by pre-treatment with the anti-
Lewis antibodies, SEQ and TSST-1, have been shown by two studies to be
significantly more common in SIDS victims than controls [Newbould et al., 1989;
Malam et al., 1992],
Further studies using MHC II depleted cell lines or monocytes pre-treated with a
selection of anti-MHC II antibodies onto which purified Lewis3 has been passively
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adsorbed could be developed to further clarify the role of this antigen as a receptor
for the staphylococcal toxins.
The reasons underlying the observed induction of nitric oxide production in response
to synthetic Lewis3 are as yet unknown. It is possible that this is a reaction to residual
levels of preservatives or other compounds used in the production of this synthetic
oligosaccharide and that purified natural Lewis3 would not have the same effect.
Repetition of this work using the staphylococcal toxins that were not inhibited by
anti-Lewis3 to determine if the Lewis antigens are capable of blocking their ability to
induce inflammatory mediators, including NO and TNF-a, would also be useful to
complement the flow cytometry studies.
8.3 Antigenic cross-reactivity among bacterial toxins and the protective
effect of infant immunisation.
The findings of antigenic cross-reactivity between several of the staphylococcal
toxins were expected from reported similarities in their amino acid sequence and
secondary structure [Chou et al., 1973; Marrack and Kappler, 1990; Johnson et al.,
1991], Several groups have previously studied cross-reactivity between the
staphylococcal enterotoxins, A, B, and C (sub-groups 1, 2, and 3), by
immunodiffusion [Lee et al., 1980], radioimmunoassay [Johnson et al., 1972; Spero
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et al., 1978 and 1979] and immunoblot [Thompson et al., 1984] of whole and tryptic
fragments of the toxins. In general their results showed reciprocated heterologous
reactions between SEB and SEC, this contrasts with the results of this study in which
the heterologous reaction of anti-SEC! with SEB was not reciprocated by the anti-
SEB antibody and SEC], One study [Thompson et al., 1984] using a range of
antitoxins prepared in different rabbits found that out of four antitoxins prepared
against SEB only one reacted with SEB and SEC], this provides a likely explanation
for the lack of heterologous reaction of anti-SEB observed in this study. Although no
previous work appears to have been carried out on the cross reactivity of TSST-1
with the other staphylococcal toxins, reports on the similarities present in the three-
dimensional structures of TSST-1 and SEB [Swaminathan et al., 1992] support the
findings presented here.
Comparison of the direct and sandwich ELISA methods gave results which, in this
application, were contradictory to the findings of Fey et al. [1984] who found the
double antibody sandwich method to be superior to other ELISA techniques. The
results observed with the direct ELISA, although a simple assay, are in agreement
with those of the studies referred to above which used more complex and time-
consuming methods. In this application, the lack of cross-reactivity observed in the
sandwich ELISA may be due to toxin epitopes being obscured by binding to the
polyclonal capture antibody which remain available to the secondary polyclonal
antibody when the toxins are bound directly to the plate. This point could be clarified
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by using a monoclonal antibody as the capture antibody followed by the secondary
polyclonal antibody.
The reactions observed between rabbit polyclonal antibodies to the DPT vaccine and
the two most commonly isolated staphylococcal toxins from SIDS cases, SEC and
TSST-1, indicate the presence of cross-reactive epitopes. This could help explain the
epidemiological evidence that DPT immunisation reduces the risk of SIDS, and
might contribute to the observed shift in the age range of local SIDS cases following
changes in the infant immunisation schedule. Further evidence was obtained by the
ability of the antiserum to DPT to partially neutralise the toxin-induced nitric oxide
response, particularly with TSST-1. Unfortunately, it does not indicate which
component of the vaccine is responsible for this effect. Repetition of this work using
antibodies raised to the individual components of the vaccine, tetanus, pertussis and
diphtheria toxoids and both cellular and acellular pertussis vaccines will be needed
to answer this question.
8.4 Synergy between bacterial toxins in induction of inflammatory
response from human monocytes.
The ability of small amounts of bacterial toxins to act synergistically in induction of
an inflammatory response has been studied by several groups in relation to SIDS
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using animal models [Drucker et al., 1992; Sayers et al., 1995], One problem with
such an approach is that although synergy between bacterial toxins can be clearly
demonstrated in animal systems, these experiments give little information as to how
such an effect could cause death in a human infant. Other animal studies, mostly on
synergy between toxins and viral products [Sarawar et al., 1994], examined cytokine
release but this still does not necessarily represent what is occurring in a human
system. These studies have been useful as preliminary work, but assays using human
cells, such as those of Lundemose et al. [1993] are necessary to validate their results
in relation to SIDS.
Direct comparison of the results from this study and those of Drucker et al. [1992]
and Sayers et al. [1995a] was not possible as they had used crude preparations of
mixed toxins prepared from SIDS bacterial isolates rather than purified single toxins.
The findings of synergy between the staphylococcal toxins and LPS [Drucker et al.,
1992; Sayers et al., 1995a] and murine lymphocytic choriomeningitis virus (LCMV)
[Sarawar et al., 1994] are consistent with the increased levels of cytokine production
observed in this study. Further supporting evidence for the ability of TNF-a and NO
to produce a lethal outcome in response to toxin synergy is obtained from the work
of Sarawar et al. [1994], The survival of mice with an asymptomatic viral infection
subsequently challenged with a non-lethal quantity of SEB was enhanced by
blocking the effect of TNF-a, using a soluble dimeric TNF receptor-Fc fusion
protein, and NO, using the nitric oxide synthase inhibitor aminoguanidine. The
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possibility of a synergistic effect between LPS, the staphylococcal enterotoxins and
non-toxigenic strains of staphylococci such as S. epidermidis needs to be examined.
The work by Sayers et al. [1995a] demonstrated synergy between LPS and
staphylococcal strains which produced no detectable toxins. This could be due to
interactions between LPS and peptidoglycan or lipoteichoic acid which are present in
larger amounts in Gram positive bacteria. Extending the range of inflammatory
mediators examined to include EL-1, TNF-p and IFN-y might also provide clues to
how the interactions of cytokines could give rise to SIDS.
8.5 The effects of cigarette smoke and viral infection on inflammatory
responses of human monocytes.
Exposure to cigarette smoke has been identified as possibly the most important
modifiable risk factor in relation to SIDS by epidemiological studies in many
countries. Its significance is not appreciably diminished by controlling for possible
confounding factors commonly observed in the population of smokers such as lower
socio-economic class, nor is it affected by the ethnicity of the population studied.
The results of these studies have indicated that eliminating both prenatal and
postnatal exposure to tobacco smoke could reduced the total number of SIDS deaths
by between 12 [Malloy et al., 1988] and 66% [Brooke et al., 1997],
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Several hypotheses have been proposed to explain the pathological role of tobacco
smoke components in SIDS. These can separated into two groups:
(1) prenatal effects including reduction of birth weight [Elwood et al., 1987; Brooke
et al., 1989], chronic fetal hypoxia [Bulterys et al., 1990], disturbance of normal lung
development [Martinez, 1991] and damage to the fetal brainstem [Krous et al.,
1981];
(2) effects of smoking in the infant's first year of life, passive inhalation of smoke
increases an infant's susceptibility to respiratory tract infections [Fergusson et al.,
1980; Taylor and Wadsworth, 1987] and reduction of peripheral arterial
chemoreceptor ability to detect lowered blood oxygen levels [Holgert et al., 1995],
Despite the large number of noxious compounds present in tobacco smoke such as
tar and CO, practically every study in the literature has concentrated on the effects of
nicotine alone. For the purposes of this study it was decided that water soluble
components of cigarette smoke would give a more accurate picture of the ability of
passive smoke inhalation to stimulate an inflammatory response as it would contain
the majority of the components capable of being absorbed into the blood stream.
Peripheral blood monocytes were used in this study rather than alveolar macrophages
as they are easily obtainable in sufficiently large quantities. They are also less likely
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to have been stimulated by inhaled antigens prior to the experiments. The L-929
bioassay for the detection of TNF-a was used throughout this study as, unlike ELISA
systems, it measures the amount of biologically active TNF-a present in a sample
rather than total TNF-a, a percentage of which will be rendered inactive either by
binding to soluble TNF-a receptors or partial degradation by monocytes.
Increased production of TNF-a was expected in response to the virus, toxin and
cigarette smoke extract challenges; however, the observed reduction in nitric oxide
levels, as previously noted by Kharitonov el al. [1995] in studies involving both
habitual and episodic smokers, could have serious consequences if they occur in the
lungs of an infant with a respiratory tract infection. It is suggested that NO plays a
protective role in asthmatic reactions by counteracting bronchoconstriction induced
by inflammatory mediators [Barnes and Liew, 1995], a view which is supported by
evidence of a small bronchodilatory response observed in asthmatic patients inhaling
high concentrations ofNO. Removal of this protective mechanism and a concomitant
increase in TNF-a levels could result in severe bronchoconstriction and hypoxia.
8.6 Possible applications of this study.
The results of this study suggest possible intervention strategies which could be
useful in further reducing the number of SIDS deaths:
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(1) Development of vaccines against the staphylococcal toxins identified in S1DS.
As whole cell vaccines against S. aureus do not appear to be particularly effective,
even though antibody titres were raised incidence of infection was not reduced
[Poole-Warren et al., 1991], This is an effect observed in natural repeated exposure
to S. aureus [Wergeland et al., 1989], Development of a vaccine to the superantigen
SEA is currently underway using genetically attenuated mutants of the toxin in which
the MHC class II binding site of the toxin is altered. This prevents it from binding
outwith the antigen binding groove and allows it to be processed as a normal antigen
[Bavari et al., 1996], This has provided complete protection from challenge with the
wild type toxin in mice. Further development of such vaccines and identification of
shared epitopes on the toxins might eventually provide a vaccine capable of
protecting humans from several, if not all, of the staphylococcal toxins.
(2) Identification of epitopes in the DPT vaccine that induce antibodies cross-
reactive with the staphylococcal toxins would allow future development of DPT
vaccines to optimise their protective effects against the staphylococcal toxins.
(3) A program of immunisation with non-toxic fragments of SEC and TSST-1 may
prevent the observed decrease in antibodies to these toxins in women in the third
trimester of pregnancy possibly resulting in higher levels of transplacental^ acquired
immunoglobulins to these toxins in the infant.
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The use of such intervention strategies could protect younger infants and those
identified as being at risk from SIDS during the window of susceptibility caused by
waning maternal antibody levels in the second month after birth.
8.7 Future work
Further work is required to clarify the mechanisms underlying some of the
observations made in this study and to provide extra information for the development
of intervention strategies to further reduce SIDS. Extending the range of
inflammatory cytokines examined to include the other important mediators of the
innate immune response such as IL-1, IFN-y, TNF-P and those of the acute phase
response would allow development of a cytokine profile of response to combinations
of bacterial toxins and virus infection. This could be of use in further elucidating the
role of infection in SIDS.
Assessment of the levels of antibodies to the staphylococcal toxins and LPS required
to reduce the effect of these toxins on inflammatory cells would be helpful for the
development of a passive immunisation strategy for infants identified as being at risk
of SIDS. The contribution of physiological changes to a window of susceptibility to
the effects of inflammatory mediators could also be examined using Cortisol or other
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glucocorticoids in the monocyte challenge assay to examine their ability to reduce
inflammatory responses to toxic stimuli.
Repetition of this work using other bacterial antigens such as endotoxins of different
species and extracts of less toxigenic staphylococci and other inflammatory cells,
particularly mast cells, could identify other combinations of infectious agents and
host responses capable of triggering a potentially fatal outcome.
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